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Summary (English)
Fractionated radiotherapy for cancer treatment is a ﬁeld of constant innovation.
Developments in dose delivery techniques have made it possible to precisely
direct ionizing radiation at complicated targets. In order to further increase tu-
mour control probability (TCP) and decrease normal-tissue complication prob-
ability (NTCP), margins used to account for interfraction and intrafraction
anatomical changes and motion need to be reduced. This can only be achieved
through proper treatment plan adaptations and intrafraction motion manage-
ment.
This thesis describes methods in support of image-based treatment replanning
and real-time intrafraction guidance techniques. The selected contributions de-
tail a number of ﬁndings and techniques, in particular:
 For ten head & neck cancer patients, changes in tumour density were
well described by linear functions with patient-speciﬁc slope and intercept.
This is of particular interest for proton therapy as delivered dose to a tissue
and calculated dose distributions rely on density. Furthermore, tumour
density changes might be indicative of treatment response.
 It is demonstrated how spatially varying elasticity parameters can be em-
ployed in image registration to encourage bone rigidity and local tissue
volume change only in the gross tumour volume and the lungs. This is
highly relevant in adaptive radiotherapy when modelling signiﬁcant tu-
mour volume changes.
 It is described how cone beam CT reconstruction can be modelled as a
deformation of a planning CT scan of the same patient, using a non-
ii
parametric diﬀusion based deformation model, opening the door to the
use of a number of advanced non-parametric algorithms. An advantage
of reconstruction by deformation is that no subsequent image registration
is needed in order to obtain the deformation which can be employed for
contour propagation in adaptive radiotherapy.
 MRI-radiotherapy devices have the potential to oﬀer near real-time intra-
fraction imaging without any additional ionising radiation. It is detailed
how the use of multiple, orthogonal slices can form the basis for reliable
3D soft tissue tracking.
Summary (Danish)
Fraktioneret stråleterapi til behandling af cancer er et felt med konstant innova-
tion. Udviklingen i dosisplanlægning og behandlingsteknik har gjort det muligt
at levere ioniserende stråling præcist til komplicerede mål. For at øge chancen
for tumorkontrol yderligere og sænke sandsynligheden for normalvævskompli-
kationer er det nødvendigt at reducere margener for inter- og intrafraktions
anatomiske ændringer og bevægelse. Det kan kun opnås gennem passende æn-
dringer af behandlingsplanen undervejs i behandlingsforløbet og håndtering af
intrafraktionsbevægelser.
Denne afhandling beskriver metoder, der understøtter billedbaseret genplanlæg-
ning af behandling og realtids, intrafraktions-tilretningsteknikker. De udvalgte
bidrag beskriver en række resultater og teknikker, deriblandt:
 For ti hoved-halscancerpatienter var ændringer i tumordensitet velbeskre-
vet af lineære funktioner med patientspeciﬁk hældning og skæring. Dette
er særligt relevant for protonterapi, hvor den leverede dosis til et væv
og dosedistributioner, afhænger af densiteten. Derudover kan ændringer i
tumordensitet, muligvis være indikativt for behandlingsrespons.
 Det bliver demonstreret, hvordan spatielt varierende elasticitetsparame-
tre kan benyttes i billedregistrering, til at tilskynde knoglerigiditet samt
lokale ændringer i vævsvolumen begrænset til tumorvolumener og lunger.
Dette er meget relevant i adaptiv stråleterapi, når store volumenændringer
modelleres.
 Det bliver beskrevet hvordan cone beam CT rekonstruktion kan model-
leres som deformation af et planlægningsscan af den samme patient ved
iv
brug af en ikke-parametrisk, difussionsbaseret deformationsmodel, hvilket
åbner op for at bruge et antal avancerede ikke-parametriske algoritmer.
En fordel ved rekonstruktion ved deformation er, at ingen efterfølgende
billedregistrering er nødvendig for at estimere denne deformation, der kan
bruges til propagering af indtegninger.
 MRI-stråleterapiapparater har potentialet til at muliggøre lav-latens intra-
fraktions-billedoptagelse uden yderligere stråledosis. Det beskrives hvor-
dan brugen af multiple ortogonale billedplaner kan udgøre en basis for '3D
tracking' af blødt væv.
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Part I
Introduction

For every complex problem
there is an answer that is
clear, simple, and wrong.
H. L. MENCKEN
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Chapter 1
Background
Cancer is a disease involving unregulated cell growth, tumour invasion of healthy
tissue and metastatic spread to secondary sites. Depending on the site and stage,
cancer may cause tissue destruction, organ compression, organ obstruction, in-
fection, anaemia, pain and for many patients even death. Cancer remains one
of the leading causes of death in both economically developed and developing
countries. In 2008 the global incidence of cancer was approximately 12.7 million
with a mortality of 7.6 million. Among females, breast cancer is the leading
cause of cancer deaths worldwide, accounting for 23% of all cancer cases and
14% of the total cancer deaths. Lung cancer is the leading cause of cancer death
among males, accounting for 17% of all cancer cases and 23% of the total cancer
deaths. (Jemal et al. 2011)
In radiotherapy for treatment of cancer, targeted ionizing radiation is used to
control or kill malignant tumour cells. Ionizing radiation inﬂicts damage to the
genetic material of exposed cells, leading to cellular death. The tumour control
probability (TCP) is proportional to the delivered radiation dose, within certain
dose intervals (Verellen et al. 2007). Escalation of dose to the tumour volume is
limited by the fact that radiation is also deposited in the surrounding healthy
tissue and nearby organs at risk (OAR). Exploiting the fact that the capability
of normal tissue to repair deoxyribonucleic acid (DNA) damage induced by low
radiation doses is greater than that of tumour tissue, the long term normal-tissue
complication probability (NTCP) is reduced by treatment fractionation. In
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fractionated radiotherapy, the total dose is typically delivered in 25-35 fractions
of 1.8-2.0 Gray (Gy) per day, allowing for the surrounding healthy tissue and
OAR to repair some of the damage caused by the radiation between fractions.
The aim of radiotherapy is to deliver a prescribed dose, e.g. 70 Gy, to tumour
cells while minimising the dose to all OAR. Radiotherapy is usually planned on
the base of a positron emission tomography/computed tomography (PET/CT)
scan that oﬀers both anatomical and biological/functional information. This
treatment plan is followed during delivery of each successive treatment fraction,
making daily setup of a patient's position critical to accurate delivery. Prior to
each daily fraction, image-guidance is employed to position the patient according
to his/her treatment planning PET/CT scan in an eﬀort to avoid changes to
the prescribed dose distribution. Exact positioning, however, may not account
for possible interfraction changes in the anatomy, including general weight loss,
tumour shrinkage/progression, oedema, bladder ﬁlling, bowel peristalsis, etc.
These changes are traditionally accounted for by adding appropriate margins to
the target volume. Wider margins ensure that the prescribed dose is delivered
to the intended volume but also inevitably increases dose to OAR, thereby
increasing the NTCP.
In adaptive radiotherapy (ART) the aim is to decrease the need for wide margins
by adapting the treatment plan to changes in anatomy as they occur during
a course of fractionated radiotherapy. ART employs image-based procedures
for interfraction treatment plan adaptations as well as for intrafraction motion
compensation.
The following sections introduce adaptive radiotherapy as well as key concepts
relevant to the ﬁeld.
1.1 Radiotherapy for treatment of cancer
1.1.1 Tumour formation
Cancer is a disease characterised by unregulated (autonomous) cell growth, in-
vasion and disruption of nearby tissues, and lymphogeneous or haematogenous
spread to distant parts of the body (metastasis). Cancer is caused by changes
of cell genes that regulate cell growth and diﬀerentiation. Two types of genes
may be altered: proto-oncogenes and/or tumour supressor genes. When altered,
proto-oncogenes may become oncogenes which encode proteins that promote cell
division and survival. Over-expression or ampliﬁcation of these genes promote
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tumour formation. Tumour supressor genes inhibit cell division and survival.
Mutations to these genes may lead to inactivation and promotion of tumour
formation. In many cancers the TP53 gene that encodes tumour protein 53
(p53) is altered. Cells with a defective p53 tumour suppressor gene do not un-
dergo programmed cell death (apoptosis). Typically, it takes more than a single
genetic change for a cell to become malignant. (Specht 2012)
Genetic changes leading to tumour formation can be caused by the following
(Specht 2012):
Chemical agents Tobacco smoking is the cause of most lung cancers, but also
associated with oral, nasal, pharyngeal, laryngeal, kidney, bladder and
pancreatic cancers. Other noteworthy chemicals associated with cancer
include asbestos (mesothelioma), aniline dye (bladder cancer), wood dust
(sino nasal cancer), aﬂatoxin (liver cancer), alkylating cytostatics (leuk-
emia).
Physical agents Ionizing radiation increases the risk of cancers in the irradi-
ated area. Sources include background radiation, mainly from radon, and
X-ray imaging. Ultraviolet light increases risk of melanomas and skin can-
cer. Chronic mechanical irritation of mucous membranes (prosthetics in
the oral cavity, kidney stones, gall stones, etc.) or chronic inﬂammation
(chronic ulcerative colitis, leg ulcers, etc.) can also lead to cancer.
Infections Human papillomavirus (HPV) is the cause of 70% of cervical cancers
as well as oropharyngeal cancers. Epstein-Barr virus is contributory factor
in the development of B cell lymphomas, such as Hodgkin's lymphoma and
naspharyngeal carcinomas. Hepatitis B and C can cause hepatocellular
carcinomas.
Immunological factors Immunosuppression due to e.g. AIDS or the use of im-
munosuppressive drugs following organ transplants can contribute to the
development of especially lymphomas.
Hereditary factors A number of genetic defects increase the risk of certain can-
cer types, e.g. mutations of the BRCA1/BRCA2 genes (breast cancer),
mutations of the APC gene (colon cancer).
1.1.2 Tumour metastasis
Metastasis is the spread of neoplastic cells from a primary malignant tumour
to a non-adjacent organ or part of the body, where they become established as
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secondary tumours. The most important types of metastases are (Nowak et al.
2004)
Haematogenous metastasis Aggressively invasive tumours easily penetrate the
thin endothelial cell layer of capillaries and veins. The low intercellular
adhesiveness of tumours allow cell emboli to separate from the tumour
and be carried in the blood stream. The emboli are ultimately carried to
the pulmonary or other organ's capillaries where they lodge and develop
as secondary tumours.
Lymphogeneous metastasis When invasive tumours penetrate lymphatic vessels
and emboli dislodge, they can lodge in the reticular tissue of upstream
lymph nodes.
Metastasis via body cavities Tumour invasion can penetrate the surface of the
organ and spread to other organs through body cavities such as the peri-
toneum. Abdominal tumour spread is aided by gravity as well as peri-
staltic and diaphragm movement.
1.1.3 Therapy modalities
In general, treatment depends on cancer type, and spread. If feasible, therapy
is curatively intended. In cases where cancer is widespread and cure is not
possible, therapy is palliative. Antitumour therapy focuses on the removal or
destruction of the tumour. All techniques aim to maximise tumour cell killing
while minimising normal tissue damage. The most important therapy modalities
are (Nowak et al. 2004; Specht 2012):
Surgery Surgery physically removes the involved tissues from the body. For
clearly demarcated benign tumours in non-critical tissues surgery is a cur-
ative treatment. For malignant tumours with irregular margins, invasive
growth patterns and/or metastatic involvement, complete surgical removal
is more complicated and adjuvant therapy might be necessary for curative
treatment.
Radiotherapy In radiotherapy, ionizing radiation is used to induce tumour cell
death. For clinical use, electromagnetic radiation (X-ray or Gamma radi-
ation) or particle radiation (electron, beta particle, or proton radiation)
are employed.
Systemic therapy Systemic therapies include treatment with cytotoxic or cyto-
static drugs, targeting rapidly dividing cells, as well as some newer biolo-
gical therapies that for example target proteins expressed only by cancer
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cells or modify the immunological response, and hormone therapy that
block the eﬀect of hormones in some hormone sensitive cancers.
1.1.4 Radiotherapy
The primary biological eﬀect of ionizing radiation is damage to cellular DNA.
While free electrons can directly damage DNA molecules it is more likely to
interact with a water molecule and produce a free radical which in turn can
indirectly damage nearby DNA molecules. The cellular response to damaged
DNA depends on cell type and radiation dose. A number of factors inﬂuence
cell response (Specht 2012):
Repair mechanisms Irradiated cells are to a varying degree able to repair part
of the inﬂicted damage as long as the total dose is delivered in smaller
quantities (fractions) and given they have suﬃcient time to complete the
repairs (approximately six hours). Tumour cells and normal tissues with
acute radiation reaction, e.g. bone marrow and intestinal epithelium, ex-
hibit limited repair. Some normal tissue types that display signiﬁcant late
eﬀects to radiation exhibit substantial repair of DNA damage at low ra-
diation levels. It is thus advantageous to deliver the total dose in smaller
fractions of typically 1.8-2.0 Gy in order to achieve a profound eﬀect on
tumour tissue with limited late eﬀects to normal tissue.
Cell proliferation In fractionated radiotherapy, surviving cells are able to pro-
liferate in between fractions. Consequently, it is important to keep time
between fractions to a minimum.
Oxygenation Hypoxic cells are relatively radiation resistant.
Cell cycle Cells sensitivity to radiation varies throughout the cell cycle. The
sensitivity is greatest late in the Gap 1 phase and Synthesis phase, and
least in the Gap 2 phase and early in the mitosis.
Cells that are damaged to such a degree that they cannot survive and divide
may undergo diﬀerent processes:
- Apoptosis or programmed cell death through damage to the mitochondria
with activation of the caspase cascade.
- Necroptosis through hyperactivation of an enzyme involved in DNA repair.
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- Mitotic catastrophe, caused by aberrant cell cycle progression or mitosis.
Such cells may then go into senescense or die by apoptosis or necroptosis.
- Autophagy, characterized by sequestration of cell components in auto-
phagic vesicles where they are degraded, providing material for new syn-
thesis processes.
- Senescence, where cells enter a state of permanent cell cycle arrest, while
remaining active in terms of metabolism.
Photon therapy employing linear particle accelerators (linacs) is currently the
predominant radiotherapy modality. Figure 1.1 shows a linear accelerator. Lin-
ear accelerators increase the velocity of charged subatomic particles or ions along
a linear beamline, by means of a series of oscillating electric potentials. In ex-
ternal beam radiotherapy devices, monoenergetic electron beams between 4 and
25 MeV are directed at a high-density, water-cooled tungsten target to produce
high-energy photons with a spectrum up to and including the electron energy.
The photon treatment beam passes through, and is shaped by, a multileaf col-
limator (MLC), focusing the radiation towards the target volume. Figure 1.2
shows how the photon beam is collimated by the MLC. The patient is positioned
on the couch. The gantry rotates around the patient, enabling the treatment
beam to target the tumour from all sides and thereby focusing the delivered
radiation dose.
Figure 1.3 shows a ﬂowchart for a typical course of radiotherapy. Prior to
initiating treatment, a set of 3D planning images are obtained and volumes of
interest are delineated. The treatment plan is optimized according to desired
doses to delineated volumes. During a course of fractionated radiotherapy it
may become necessary to update the treatment plan due to changes in patient
anatomy. (Grégoire et al. 2011)
1.2 Imaging modalities for radiotherapy planning
For many tumour sites, radiotherapy is planned based on 3D positron emission
tomography/computed tomography (PET/CT) scans. A PET/CT scan is a
fusion of a CT scan that provides anatomical information, and a PET scan
that provides biological/functional information. For some tumour types and
locations it is beneﬁcial to acquire 3D magnetic resonance imaging (MRI) scans
as well, as MRI oﬀers better soft tissue contrast than CT. MRI images can be
fused to PET/CTs using image registration (see Section 2.3). Recently positron
emission tomography/magnetic resonance imaging (PET/MRI) scanners have
become available as well.
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Figure 1.1: The Varian Clinac®iX linac radiotherapy device with integrated
CBCT scanner. Image courtesy of Varian Medical Systems, Inc.
All rights reserved.
1.2.1 Computed tomography (CT)
In computed tomography (CT) imaging, X-ray technology is employed to visu-
alise tissue density. Tomography signiﬁes volume imaging in the sense that 3D
information about the scanned subject is acquired. In traditional X-ray trans-
mission imaging, photons with wavelengths ranging between 0.01 and 10.0 nm
and energies between 100 eV and 100 keV are generated and directed towards
the subject under investigation. At kV energies, photoelectric absorption is
dominant, depending on (and about proportional to) atomic number, while at
MV energies, Compton scattering is dominant, depending mainly on electron
density. Opposite the X-ray source, the unabsorbed photons are registered on
photographic ﬁlm or by scintillation detectors. In conventional X-ray images,
volumetric information is lost when acquiring a transmission image of a 3D sub-
ject on a 2D image plane. A given point on the 2D image plane describes the
integral attenuation along the beam line between that point and the X-ray point
source. In CT imaging, projections are obtained from a multitude of imaging
angles, making it possible to perform a mathematically based tomographic re-
construction of the 3D information otherwise lost (Cormack 1963; Hounsﬁeld
1972; Hounsﬁeld 1973). The CT scan oﬀers 3D information about tissue density
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Figure 1.2: Left: An external beam radiotherapy device shaping the X-ray
beam with a multileaf collimator (MLC). Right: Close-up of an
MLC. Images courtesy of Varian Medical Systems, Inc. All rights
reserved.
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2.4. Organs at risk
The organs at risk (OAR) or critical normal structures are tis-
sues, which if irradiated could suffer signiﬁcant morbidity, and
thus might inﬂuence the treatment planning and/or the dose pre-
scription. In principle, all non-target tissues could be organs at risk.
However, normal tissues considered as OARs typically depend on
the location of the CTV and/or the prescribed dose. Care will have
to be given to the delineation of OARs: for example, for “tubed”
organs (e.g. the rectum) the wall and not the full organ including
the content will be delineated; also for ﬁnite normal tissues (e.g.
the parotids, the lungs) the full organ will have to be delineated as
the ﬁgures of merit to evaluate radiation toxicity in these organs
(e.g. mean parotid dose, V20Gy for the lung) will have to be related
to the full volume. Recent recommendations have been published
regarding normal tissue tolerance [20].
As is the case with the planning target volume, uncertainties
and variations in the position of the organs at risk during treat-
ment must be considered to avoid serious complications. For this
reason, margins have to be added to the OARs to compensate for
these uncertainties and variations, using similar principles as for
the PTV. This leads, in analogy with the PTV, to the concept of plan-
ning organ at risk volume (PRV). The selection of the margin will
however depend on the structure of the OAR, being more critical
for organs such as the spinal cord or nerves than for organs such as
the parotid glands or the lungs. In practice, for these latter organs,
the OAR to PRV margin could be set to 0mm.
3. Planning aims and treatment optimization
In IMRT, the distribution of dose to multiple volumes is pri-
oritized and tailored through an iterative process, referred to as
“optimization”. As shown in Fig. 1, the process consists of three
major components: the deﬁnition and description of the “planning
aims” using image-based information from which all of the vol-
umes of interest (e.g. GTVs, CTVs, OARs, PTVs, PRVs) are delineated
and the desired absorbed dose levels are speciﬁed; a complex beam
delivery “optimization” process to achieve and, if needed, modify
the initial “planningaims”; a complete setofﬁnally acceptedvalues,
whichbecomes the “treatment prescription” and, togetherwith the
required “technical data” represent the “accepted treatment plan”.
The planning aims are dosimetric goals used to develop the
treatment plan. These goals can bedeﬁned for any speciﬁed volume
including the PTV(s) and PRV(s), for which constraints are needed.
Typically multiple constraints are deﬁned such as mean or median
dose, dose to “x”% of a volume (e.g., D2% or Dnear-maximum dose) or
volume receiving at least an absorbed dose D (e.g. V20Gy). Also in
the optimization process, priority of one constraint over another,
and/orpriorityof onevolumeover another are speciﬁed.All of these
constraints are deﬁned in the planning protocol. To initiate the
planning process, medical physicist or technologist sometimes use
so-calledartiﬁcial dose-volumeconstraints,whichmaybedifferent
from the desired ones or from clinically relevant dose constraints.
The dose-volume constraints will then be modiﬁed iteratively to
achieve the best plan.
When the optimized dose distribution is accepted by the
physician, the prescription and technical data are ﬁnalized. The
treatment plan includes the ﬁnal prescription as well as all tech-
nical data required for treatment delivery. The prescription is a
descriptionof the volumesof interest, thedose and/or dose-volume
requirements for the PTV, the fractionation scheme, the normal tis-
sue constraints, the dose distribution(s) that have been planned.
This ﬁnal process is the responsibility of the treating physician. The
prescription is then referred to as the ﬁnally accepted set of val-
ues of the modiﬁed planning aims in the treatment plan after an
optimization process.
Fig. 1. Flow chart of a typical course of radiotherapy.
4. Dose-volume prescription, reporting and recording
The main reason for the use of dose-volume reporting and
recording in IMRT is that the coverage of the PTV by a speciﬁc
absorbed dose can be explicitly determined from a dose-volume
histogram, and be better controlled through optimized planning.
The use of dose-volume reporting and recording instead of report-
ing and recording the more established absorbed dose at the
ICRU Reference Point is predicated on the use of an adequate
dose-calculation system. Recently, model-based dose-calculation
algorithms, such as the convolution/superposition method or
Monte Carlo simulation have been adopted and provide accurate
absorbed-dose calculations even in situations of tissue hetero-
geneity such as the lung. It is recommends that the users of
treatment-planning systems ensure that treatment planning sys-
tems have the ability to compute the absorbed dose accurately for
small ﬁelds, inhomogeneous tissues, and in regions in which there
is electronic disequilibrium. The absorbed dose in Gray to a small
mass of water within the heterogeneous tissue is the relevant dose
to compute. Thismeans thatdirect computationofdosewithMonte
Carlo simulation to the tissue (including the correct atomic compo-
sition and density) must be converted to the dose to a small mass
of water within the tissue type.
Prescription values for IMRT should be based on statistically
meaningful dose-volume speciﬁcations and not on specifying the
dose only at a single point. The older speciﬁcation of an ICRU refer-
ence point dose is not recommended for IMRT. Neither is the mini-
mumdose to thePTV. That is because theminimumdose represents
Figure 1.3: Flowchart of a typical course of radiotherapy. Reprinted from
Grégoire et al. 2011 with permission.
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Substance HU
Air -1000
Lung -500
Fat -100 to -50
Water 0
CSF 15
Kidney 30
Blood 30 to 45
Muscle 10 to 40
Grey matter 37 to 45
White matter 20 to 30
Liver 40 to 60
Bone 700 (trabecular bone) to 3000 (compact bone)
Table 1.1: Hounsﬁeld units of selected tissues and substances.
on the Hounsﬁeld scale, as deﬁned by Brooks et al. 1980. The Hounsﬁeld unit
(HU) is related to the linear attenuation coeﬃcient of the tissue by
HU = 1000×
(
µ
µwater
− 1
)
(1.1)
Table 1.1 lists HU values of selected tissues. An important drawback with CT
imaging is the ionizing dose delivered to the patient, ranging from 1-10 mSv
Shrimpton et al. 2006. For a more comprehensive introduction to CT imaging
see e.g. Beutel et al. 2000.
1.2.2 Positron emission tomography (PET) and PET-CT
fusion
In PET imaging, a 3D image of biological activity within the body is produced
through the detection of gamma rays that are emitted when injected radioiso-
tope tracers decay and release positrons.
First, the patient is injected with a radioisotope tracer. As the radioisotope de-
cays, positrons are emitted. As the positrons collide with electrons, two photons
(gamma rays) are emitted in opposite directions. The photons are detected in
a ring of discrete scintillation detectors surrounding the patient. As the two
photons are emitted at a 180◦ angle, the line of response is between the two de-
tectors on the ring recording the event. Localisation of the event along this line
can be calculated from the very small time diﬀerence in detection. (Robertson
et al. 1972; Phelps et al. 1975; Cherry et al. 1997; Schmand et al. 1998)
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Total photon emission is attenuated by the tissue, much like in CT. Since
high density tissue is more likely to absorb photons, and since emission from
deep within the body is more attenuated than emission from the outer layers,
attenuation correction is critical to avoid errors in the 3D reconstruction. The
correction is based on a 3D map of tissue density. For this purpose, a CT scan
is used.
Ido et al. 1978; Phelps et al. 1979 described the synthesis and ﬁrst use of the 2-
deoxy-2-(18F)ﬂuoro-D-glucose (FDG) tracer. It is the most utilized radioisotope
tracer for radiotherapy treatment planning. Since tumours have a high glucose
uptake, due to increased cell proliferation, this glucose analogue is concentrated
in tumours. FDG tracers are used for functional analysis of brain, heart and
lungs as well. Using PET, it becomes easier to see whether the primary tumour
has metastasised.
A combined PET/CT scanner was ﬁrst described by Beyer et al. 2000. Until
then the scans were acquired using separate devices. Combined scanners are
beneﬁcial for optimal alignment of the scans for the fusion. Figure 1.4 shows a
fusion of a CT and a PET scan.
1.2.3 Magnetic resonance imaging (MRI) and PET-MRI
fusion
In magnetic resonance imaging (MRI) the magnetic properties of hydrogen
atoms in water and fat molecules are exploited in order to produce detailed
tomography images with high soft-tissue contrast. Unlike CT, it even provides
contrast between soft tissues with same density, making it well suited for imaging
of tumours.
The subject is positioned in a powerful magnetic ﬁeld, aligning the spin axis
of the magnetic hydrogen atom nuclei in the human body along the magnetic
ﬁeld. A little more than half of the nuclei are aligned parallel to the ﬁeld, in a
low energy state. A little less than half are aligned anti-parallel to the magnetic
ﬁeld, 180◦ rotated, in a high-energy state. There is a linear relationship between
the magnetic ﬁeld strength and the energy diﬀerence between the low and high
energy states. The same goes for ﬁeld strength and spin excess - the excess
number of spins in the low energy state.
When applying a radio frequency (RF) ﬁeld (an oscillating magnetic ﬁeld),
perpendicular to the main magnetic ﬁeld, at the proton precession frequency
(the resonance frequency), some excess spins in the low energy state transition
into the high energy state, producing a ﬂip of the net magnetization. When the
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RF ﬁeld is turned oﬀ, a signal is induced in a receiver coil as the excess spins
transition back to the low energy state. Hydrogen atoms in diﬀerent tissues have
diﬀerent magnetic properties, hence diﬀerent resonance frequencies, making it
possible to create fat- or water-weighted images, for example.
As the precession frequency is dependent on the main ﬁeld strength, diﬀerent
parts of the body can be examined by diﬀerent RFs when applying gradients to
the main ﬁeld. Hence, a 3D image can be constructed.
(Damadian 1971; Lauterbur 1973; Mansﬁeld 1977; Damadian et al. 1976)
Judenhofer et al. 2008 described the ﬁrst prototype combined PET/MRI scan-
ner. These systems are already commercially available. As PET must be at-
tenuation corrected it is still being investigated how this is best done using the
MRI image that, unlike CT, does not inherently provide tissue attenuation in-
formation (Hofmann et al. 2009). In addition, PET/MRI has some advantages
over PET/CT:
- PET/MRI systems are very promising in terms of alignment precision
between the functional and anatomical image information. While PET/CT
is acquired sequentially, PET/MRI can be acquired simultaneously.
- Unlike CT, MRI does not add additional radiation dose.
- In addition to structural information, MRI oﬀers a variety of tissue con-
trasts, water diﬀusion imaging, magnetic resonance spectroscopy (MRS),
and functional MRI (fMRI) where the haemodynamic response is quan-
tiﬁed. Judenhofer et al. 2008; Kjær et al. 2013; Dirix et al. 2009; Smith
et al. 2004
Figure 1.4 compares the PET/CT and PET/MRI for a patient with cervical
cancer.
1.3 Radiotherapy planning
Patients present to the oncology department with a suspicion of cancer1 and
they are subsequently referred for site-speciﬁc diagnostic and staging studies,
including imaging with CT or PET/CT for cases where functional imaging is
expected to be beneﬁcial. In some cases, where soft tissue contrast is import-
ant, such as for brain or cervix cancers, an additional MRI might be acquired.
1At Rigshospitalet, patients present with a diagnosis as they are referred from regional
hospitals.
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• Routine access to a suitable multi-modality viewing
and analysis platform.
Comparative study designs must account for variations
of the imaging methodology between PET/MR systems and
PET/CT and MR-only systems. On the PET side, meth-
odological and technical variations between PET/CT and
PET/MR include patient positioning (arms up or down), the
ability to perform Time-of-Flight emission acquisitions, the
access to image reconstruction with resolution modeling
and additional reconstruction parameters. Thus, a blinded
comparison is frequently obstructed by the fact that
oncology patients are generally positioned with their arms
up in PET/CT, whereas they keep their arms down during a
PET/MR examination given the longer examination time,
smaller bore size and the possible presence of a MR head/
neck coil. Also, such studies mandate a full understanding
of potential methodological pitfalls and image artifacts
arising mainly from the use of the MR for the purpose of
attenuation correction of the PET emission data [56]. On
the MR side, the full range of organ-specific MR receiver
coils used in clinical practice is not yet available for
combined PET/MR examinations also due to the specific
attenuation correction problem with hybrid PET/MR sys-
tems [57].
Ideally, future technical development will allow hard-
ware combinations of PET and MR to perform simulta-
neously any type of acquisition previously made separately
on PET and MR, but may also lead to the development of
new imaging paradigms, with methodologies differing
from those traditionally used in PET and/or MR.
Conclusion
The number of installed PET/MRI systems is rapidly
increasing. PET/MRI combines two complementary func-
tional imaging modalities bringing together non-invasive
tracer imaging and advanced anato-functional imaging.
This unique combination is likely to promote better tissue
characterization, for diagnosing, staging and tailoring
therapy. More importantly, we believe that response
monitoring in cancer patients may improve dramatically
using functional information from both PET and MRI. Our
first experience using integrated PET/MRI as part of our
Fig. 3 31-year- old female patient with newly diagnosed cervical
cancer referred for an [18F]-FDG-PET/CT examination for re-staging
following radiotherapy. The PET/CT scan was performed 67 min post
injection of 375 MBq [18F]-FDG. The subsequent PET/MRI was
performed 131 min p.i. with arms up using phased array body and
spine coils (sagittal MR: T2-TSE with TR/TE: 6,080/86 ms). PET/CT
shows the primary tumour in the cervix behind the urine bladder and a
lymph node in the pelvis, both indicated with arrows. PET/MR
reveals the same findings but with a more precise definition of the
primary tumor
Magn Reson Mater Phy (2013) 26:37–47 43
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Figure 1.4: Imaging of a patient with cervical cancer. Top: PET/CT shows
the hypermetabolic primary tumour in the cervix, posterior to the
urinary bladder, as well as an involved lymph node, both indicated
with arrows. Bottom: PET/MRI reveals the same ﬁndings but
with a more precise deﬁnition of the primary tumour. Reprinted
from Kjær et al. 2013 with permissi n.
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Recently, a PET/MRI scanner has been installed at Rigshospitalet, but it is not
yet used for routine clinical imaging. During these scans the patient is immob-
ilised, often also with a custom moulded head ﬁxation mask. It is important
that the patient maintains the same posture for both imaging and treatment in
order to achieve the planned dose delivery distribution.
After a patient has undergone a complete staging work-up, a multi-disciplinary
discussion takes place in order to determine the best treatment options for the
patient. For localised and clearly outlined tumours with no metastases it might
be possible to remove the tumour by surgical resection. For patients with local
and regional disease radiotherapy is often an option, with or without additional
systemic treatment. For patients with disseminated disease some form of sys-
temic treatment is needed, but for most solid tumours this treatment is not
curative if given alone.
1.3.1 Delineation of volumes of interest (VOI)
The target volume outline is manually delineated in each transaxial slice of the
3D structural CT scan with aid from the functional information from the PET
scan.
Three target volumes are delineated on the planning CT scan; the gross tumour
volume (GTV), the clinical target volume (CTV) and the planning target volume
(PTV). All organs at risk (OAR) and their associated planning organs at risk
volume (PRV) are also deﬁned (Grégoire et al. 2011; Halperin et al. 2008):
GTV This volume is comprised by the primary tumour and clinically detect-
able, involved regional lymph nodes and the distant metastases, if any.
Information from the PET scan is very important for locating all meta-
stases.
CTV This volume contains the GTV as well as suspected subclinical malignant
disease. Since tumours are known to demonstrate microscopic inﬁltrations,
tissue boundaries that are seemingly clear on the scans are aﬀected by some
uncertainty (Daisne et al. 2004). Statistical data and clinical knowledge
about lymph node drainage patterns for diﬀerent tumour sites may be
utilised as well (Boehmer et al. 2006; Roels et al. 2006; Grégoire et al.
2000).
PTV This volume contains the GTV and CTV and adds a margin to account
for geometric uncertainties such as (Herk 2004; Nijkamp et al. 2012)
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- The limited resolution of the imaging modalities, so-called partial
volume eﬀects (Links et al. 1998).
- Setup accuracy.
- Physiological factors such as organ motion, i.e. bladder ﬁlling, rectal
ﬁlling, peristalsis, breathing-related lung motion etc.
PRV This volume contains the OAR as well as all geometric uncertainties re-
lated to its position and contour.
1.3.2 Plan optimisation
As previously stated, the goal of radiotherapy is to deliver a prescribed dose
to the tumour in order to maximise the tumour control probability (TCP).
In this context, it should be noted that dose is usually prescribed to PTV,
which contains both the CTV and GTV. In intensity-modulated radiotherapy
(IMRT), the dose is delivered from a multitude of angles by means of a rotating
gantry of the linac. Furthermore, MLC position is modiﬁed in order to modulate
the intensity of radiation within each beam. Under supervision, the treatment
planning software optimises treatment angles and MLC position according to the
planning objectives. Figure 1.5 shows treatment plans with visualised treatment
beams for prostate and lung cancer cases.
The quality of a plan is usually evaluated in terms of cumulative dose-volume
histograms (DVHs). These histograms indicate the percentage of the volumes
that receive the prescribed dose (Lyman 1985; Lyman et al. 1987; Lyman et al.
1989). Figure 1.6 shows a typical DVH for a lung cancer patient. The DVH
curves indicate that most of the PTV and GTV receives the prescribed dose,
while the OAR are spared from receiving high doses.
Given the DVH based objectives, the plan is optimised using specialised software
that employs advanced mathematics for optimisation. Algorithms such as the
Monte Carlo method are employed for calculating the resulting dose distribution,
see e.g. Reynaert et al. 2007; Chetty et al. 2007; Shepard et al. 2002. The
treatment plan parameters that are optimised may include the selected beam
angles2, collimator angles, beam energy, MLC position, relative weighting of
each beam, and presence of wedges. The limitation of a DVH is that it does not
indicate a location of a certain dose. It is necessary for the treating radiation
oncologist to view isodose volumes on axial CT slices to know precisely where
the hot and cold spots occur, and to evaluate for adequate coverage of their
target volumes.
2Often not included as it oﬀers to many degrees of freedom.
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Figure 1.5: Left: An IMRT treatment plan for a patient with prostate cancer,
generated using EclipseTM treatment planning software. The area
of high dose (red) corresponds precisely to the tumour area being
treated. Right: A lung cancer treatment plan generated using
EclipseTM treatment planning software. Images courtesy of Varian
Medical Systems, Inc. All rights reserved.
24 Introduction
Figure 1.15: Example of a dose volume histogram (DVH) for a lung cancer
patient. It is seen the gross tumour volume (GTV) and planning target vol-
ume (PTV) receives a high uniform dose. The prescribed dose for stereotactic
body radiation therapy (SBRT) is 45 Gy. The normal tissue has a lower and
heterogenous dose as it can be seen in the lower left of the figure.
1.3.2.7 Organs at risk
The ambition of radiation therapy is the highest degree of TCP. This can be
achieved by increasing margins and prescribed dosage. But that comes with a
price for the surrounding normal tissue. The normal tissue complication prob-
ability (NTCP) describes the probability of normal tissue complication due to
radiation dose [24] . NTCP behaves like the TCP, but varies between tissue
types due to the difference in cell types, reflecting cell division rate among other
things, and tissue organisation, parallel and/or serial[159].
Delineation of OAR is therefore vital for the treatment success, defined as both
cure and lowest impact on vital body function due to the radiation treatment.
In clinical practice this does not mean a delineation of all organs in the body,
but rather a delineation of the organs, that have vital function. This is again in-
fluenced by the therapy. Adding an uncertainty margin allows the contourer to
delineate the planning organ-at-risk volume (PRV), which represents the the-
oretical location of the organ - due to errors. Dosage given to the OAR is
represented in the DVH as with the PTV. In head and neck cancer the OAR
will typically be the salivary glands, the spinal cord and the optic nerve. An
example of some of the VOIs can be seen in figure 1.16.
Figure 1.6: Example of a dose-volume histogram (DVH) for a patient with
lung cancer. Reprinted from Hollensen 2012 with permission.
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1.4 Imaging modalities available in treatment room
In addition to the linac, in-room image-guidance may be accomplished by mul-
tiple modalities including integrated cone beam CT (CBCT), CT on rails, in-
tegrated CT or integrated MRI in form of MRI-linac systems.
1.4.1 CBCT
An integrated kV CBCT-linac system was ﬁrst described by Jaﬀray et al. 2002,
see Figure 1.7 Compared to a normal CT scanner, the beam is cone-shaped
instead of fan-shaped. The detector is a ﬂatpanel and not a curved line array,
meaning that a full volume is imaged with one rotation. As one rotation takes
at least 60 seconds due to safety regulations, breath-hold scans are not feasible.
The resulting conventionally reconstructed tomographies of thorax will have
motion blurring due to breathing and cardiac motion. To some extent, Section
3.2 deals with motion blurring eﬀects.
CBCT provides a 3D assessment of patient anatomy and positioning. If acquired
daily, CBCT allows evaluation of interfraction changes in patient anatomy such
as bladder ﬁlling and rectal distension, which may cause signiﬁcant changes in
dosimetric coverage. In addition CBCT allows volumetric comparison to the
planning CT to aid in determining when a replanning CT becomes necessary.
At around 10-30 mGy, the dose is the same or higher than a conventional CT
(Islam et al. 2006; Walter et al. 2007).
Both MV and kV CBCT systems are available. MV CBCT systems use the linac
treatment beam as X-ray source and an electronic portal imaging device (EPID)
ﬂat panel detector, see e.g. Swindell et al. 1983; Midgley et al. 1998. While an
advantage of MV imaging is that it provides the beam's eye view (BEV), Groh
et al. 2002 concludes that kV CBCT oﬀers signiﬁcant performance advantages
over MV CBCT in terms of image contrast and signal-to-noise ratio (SNR) per
unit dose for visualization of soft-tissue structures. kV CBCT adds less dose
than MV CBCT (Walter et al. 2007).
Compared to conventional CT, CBCT often suﬀers from a number of quality
issues and artifacts such as motion blurring caused by the previously mentioned
long rotation time, a higher level of scatter noise related to the cone-beam geo-
metry, beam hardening eﬀects caused by the use of wide spectrum (unﬁltered)
X-ray sources, and ring artefacts due to detector or geometry imperfections
(Schulze et al. 2011). Many of these artefacts can be corrected for, see e.g.
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radiograph is known at the time of reconstruction. For systems
that are well-described by a simple rotation, the projection
geometry can be calculated from the angular increment pro-
vided the source, axis of rotation, and detector positions are
well known for at least one projection. The system under
investigation here cannot be described by a simple rotation.
The substantial mass of the X-ray tube and detector combined
with their distance from the drum face (125 cm) result in
substantial flex of these components during gantry rotation.
The calibration procedure is similar to that reported by
Fahrig and Holdsworth (41) and begins by placing a small steel
ball bearing (0.8 cm diameter) at the nominal treatment iso-
center of the treatment gantry as represented by the in-room
laser system. X-ray projections are taken of the bearing as the
gantry rotates clockwise through 360°. The centroid of the
bearing in each image is determined automatically via software
and recorded. The overall displacement of the projected bear-
ing location with respect to the detector is measured to verify
that the bearing is reasonably placed (within 0.2 cm of the
nominal axis of rotation). From this analysis, a calibration map
of centroid position vs. gantry angle is established. Due to the
presence of hysteresis effects in the motion of the gantry, the
calibration procedure is performed for a specific start angle
(180°) and direction (clockwise).
Table 1. Characteristics of imaging system components
Linear Accelerator
Manufacturer Elekta Oncology
Systems
Model SL-20, Sli/MLCi
Mass 5 ton
Range of rotation  185°
Maximum angular velocity 1 rpm
kV X-ray Source
Manufacturer Varian Associates
Model RAD-92, Sapphire
Housing
Mass (tube, housing, collimator) 44.6 kg
Anode heat capacity 600 kHU
Target angle 12°
Focal spot size (nominal) 0.6 mm
Inherent filtration 2 mm Al.
Additional filtration 0.127 mm Cu
Generator 45 kW High-frequency
Flat-Panel X-ray Detector
Manufacturer PerkinElmer
Optoelectronics
Model RID-1640 AL1
Mass 22 kg
Detector housing dimensions 67.2  59.9  4.4 cm3
X-ray converter 133 mg/cm2 Gd2O2S:Tb
Detector size 41  41 cm2
Pixel matrix format 1024  1024
Pixel pitch 400 m
Detector pixel elements a-Si:H Photodiode and
thin-film transistor (TFT)
Fill factor 0.80
Photodiode capacitance 8.4 pF
Photodiode bias voltage (V) 6 V
Photodiode charge capacity 48 pC
Charge transfer time 35 s
ASIC charge capacity 5 pC
Maximum frame rate 3.5 fps
Detector dynamic range 83 dB
Image lag 3%
Digitization 16 bits
Fig. 1. (a) Medical linear accelerator modified for kV cone-beam
computed tomography. A kV X-ray tube has been mounted on a
retractable arm at 90° with respect to the treatment source. A
large-area (41 41 cm2) flat-panel imager is mounted opposite the
kV X-ray tube on a fixed mount. (b) Photograph of the large-area
flat-panel detector employed in this investigation (black) in com-
parison to a smaller detector employed in previous investigations
and an anthropomorphic head phantom. Labels indicate the pixel
format and pixel pitch of the imagers (i.e., 1024 1024 pixels and
512  512 pixels at 400 m pitch, respectively) as well as the
approximate sensitive area (i.e., 41  41 cm2 and 21  21
cm2, respectively).
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Figure 1.7: A medical linear particle accelerator (linac) modiﬁed for kV cone
beam CT (CBCT). A kV X-ray tube has been mounted on a
retractable arm at 90◦ with respect to the treatment source. A
large-area, 41× 41 cm ﬂat-panel detector is mounted opposite the
kV X-ray tube on a ﬁxed mount. Reprinted from Jaﬀray et al.
2002 with permission.
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Figure 1.8: Left: The Siemens Primatom system. Image courtesy of Siemens
AG. All rights reserved.
Right: The Accuray TomoTherapy TomoHD system. Image cour-
tesy of Accuray, Inc. All rights reserved.
(Zhang et al. 2010; Hsieh et al. 2000; Sonke et al. 2005; Siewerdsen et al. 2006;
Wang et al. 2009; Jia et al. 2010). As some of the correction methods are based
on iterative algorithms and are thus time consuming, they are often not available
in clinical settings.
1.4.2 CT on rails and integrated CT systems
Figure 1.8 shows a Siemens Primatom system consisting of a Primus linac and
a Somatom sliding gantry CT (CT-on-rails) scanner. The couch can be rotated,
allowing for transport of the immobilised patient from the CT gantry to the
linac. The ﬁgure also shows an Accuray TomoTherapy system integrating both
CT and linac in the gantry.
Both types of systems are capable of acquiring standard CT scans before the
delivery of each fraction. The reconstructed images can be used for both patient
setup and interfraction treatment plan adaptations. Since it is the same image
modality as is normally used for planning scans, the images are easily compared
and evaluated either manually or automatically. (Uematsu et al. 1996; Uematsu
et al. 1998)
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(a) (b)
Figure 1.4: The first Utrecht mri-linac prototype. (a) rendered CAD drawing
showing the mr scanner and the linac positioned in the zero magnetic field
region; (b) photograph of the prototype showing the accelerator components on
a wooden table and copper-plated Faraday cages around the magnet.
rotating system. Communication with on-board electronics is carried out by way
of wireless ethernet. The current gantry prototype facilitates continuous rotation
at a maximum speed of 10 rpm.
(a) (b)
Figure 1.5: The current mri-linac prototype built in Utrecht; (a) rendered
CAD drawing with a human figure to be able to appreciate the size of the
machine and (b) photograph of the prototype, showing the gantry around the
magnet cryostat.
1.3 Challenges
A few interesting challenges must be solved for the mri-linac concept to be adopted
in routine clinical practise. Obviously there are many clinical challenges, since the
machine is thought to bring many new possibilities compared to conventional linear
10
Figure 1.9: The UMC Utrecht prototype MRI-linac. Reprinted from Crijns
2013 with permission.
1.4.3 Integrated MRI-radiotherapy systems
Recently, integrated MRI-radiotherapy systems have been investigated and are
currently under development, see e.g. Lagendijk et al. 2008; Raaymakers et al.
2009; Fallone et al. 2009; Dempsey et al. 2011; Dempsey et al. 2005. One such
system is already available for purchase from ViewRay, Inc. Figure 1.9 shows
the UMC Utrecht prototype system. Figure 1.10 shows the ViewRay system.
These systems integrate an MRI scanner with a linac therapy device (ViewRay
uses three Cobalt sources instead of a linac). Like an ordinary MRI scanner, it
is possible to obtain volumetric images. Like the CBCT and CT systems, these
can be used for daily treatment plan adaptation according to changes in patient
anatomy, see Section 2. Furthermore the systems are capable of intrafraction
imaging on a sub-second time scale. This is useful for treatment beam gating
or guidance, see Section 3.
Compared to X-ray based imaging, daily MRI imaging contributes with no extra
dose to the patient.
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Figure 1.10: The ViewRay MRI/cobalt therapy device. Image Courtesy of
ViewRay, Inc. All rights reserved.
1.5 Patient setup
Ahead of each fraction delivery, the patient is usually immobilised and rigidly
positioned by means of isocentric laser guidance based on skin markings placed
pre-treatment. Even though the patient is set up according to external skin
markings, the internal anatomy might deviate from when the planning CT scan
was acquired, and the target may be displaced. Immobilisation does reduce
setup errors, but still, mean setup displacement errors on the scale of 4-10 mm
have been reported (Hurkmans et al. 2001; Clippe et al. 2003; Bray et al. 2012).
A patient's position can be veriﬁed using the in-room treatment modalities, by
rigid image registration of daily images to the planning CT scan (Bel et al.
1993; Boer et al. 2001; Clippe et al. 2003). Using such methods, translation and
rotation can be determined. While conventional CT does produce images of
better quality than CBCT, transferring the patient from the the CT scanner to
the linac can introduce motion associated setup error. For linacs with integrated
imaging, veriﬁcation can often be performed during delivery as well, and the
treatment can be stopped or paused if the patient moves. Veriﬁcation can be
based on both bony and soft tissue landmarks. Due to lack of contrast, soft
tissue veriﬁcation is usually only possible for lung tumours.
26 Background
Chapter 2
Interfraction treatment plan
adaptations
One of the greatest challenges in modern radiotherapy is modifying a plan to
match tumour response during treatment. Figure 2.1 shows an example of pro-
nounced anatomic changes during treatment of a head & neck cancer (HNCA)
patient. The delineated volumes of interest clearly do not align to the anatomy
three weeks into the treatment. With current imaging, delivery and treatment
planning technology it is possible to shape and deliver dose with a level of accur-
acy and precision that is unsuitable due to the magnitude of daily setup errors
and changes in anatomy. In the near future, proton therapy will be implemented
on a large scale, highlighting the importance of higher delivery accuracy.
In adaptive radiotherapy (ART), the treatment plan is corrected according to
anatomical changes in tumour and normal tissue anatomy. The concept of ART
is not new. Technical limitations as well as additional work load of staﬀ are
holding back full-scale clinical implementation. For ART to make its way into
routine clinical use, fast, reliable, automatic methods need to be developed.
This chapter describes approaches and technologies to support ART.
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Planning CT During treatment
Figure 2: Anatomic changes can be pronounced during treatment. In this example, planning CT scan and CTV contours are shown on the
left. On the right, a mid-course CT (three weeks into treatment) demonstrates significant reduction in gross tumor (thick red line). Baseline
CTVs have been overlaid via rigid image registration. These match current anatomy poorly and in fact extend past the skin contour into air.
candidate patients who may benefit most from an adaptive
radiotherapy approach.
Parotid glands also involute during therapy (Figure 4).
Barker et al. observed that the median parotid volume loss
was 0.2 cc/day or 0.6%/day of the initial volume. At the
end of treatment, median parotid volume loss was 28.1%.
The center of mass of both parotid glands shifted medially
over time. By the end of treatment, this medial shift was
3.1 mm (range: −0.3–9.9 mm). Lee et al. acquired similar
data using daily megavoltage CT imaging [48]. Day-to-day
variations in the center-of-mass distance and volume were
1.61 mm and 4.36%, respectively. Parotid volumes decreased
with a median total loss of 21.3% and a median change rate
of 0.7%/day. Parotids migrated toward the patient center
with a median total distance change of −5.26 mm (0.00 to
−16.35 mm) and a median change rate of −0.22 mm/day.
Another CT-based study of 82 head and neck cancer patients
showed an average volume loss in parotid glands of 20.0%,
26.9%, and 27.2% after 3-week mid-treatment, at treatment
completion, and 2-month posttreatment, respectively [49].
These gland volume reductions correlated significantly with
mean dose to the irradiated glands: volume loss with
higher mean parotid doses (>30 Gy) to the glands was
significantly greater than for lower mean parotid doses
(P < .001).
Finally, nearly all patients lost weight throughout their
course of treatment. Barker et al. found that the median
weight change from the start to completion of treatment was
–7.1% (range, +5.2% to –13.0%) in their study. Reductions
in external skin contours at the level of the C2 vertebral body
and at the base of skull correlated with weight loss. Median
weight loss correlated significantly with median parotid
medial displacement over time (P < .001). This confirms
that skin contours and weight loss can potentially be
used as easy-to-measure harbingers of underlying anatomy
changes.
5. Image-Guided Adaptive Radiotherapy for
H and N Cancer
5.1. Image-Guided Approaches for H and N Radiotherapy.
The term image-guided radiation therapy (IGRT) is com-
monly interpreted as the use of in-room imaging to make
setup corrections, in particular, positional shifts. Image guid-
ance does not typically involve modification of the original
treatment plan, which means that IGRT aims at correction
of setup errors and reducing CTV-to-PTV margin. Although
there are other approaches for H and N patient setup, in-
room stereoscopic and volumetric imaging are the most
commonly used techniques for IGRT.
IGRT workflow for H and N patients is not diﬀerent
from other treatment sites, with the notable exception
that an ROI should be explicitly identified by the treating
physician as a part of patient’s treatment directive. Previous
studies have provided suﬃcient evidence that the relative
movement of diﬀerent ROIs can be significant in the H
and N region. Ignoring these diﬀerences in diﬀerent regions
would introduce additional setup uncertainties [36, 43]. The
selection of ROI depends on the treatment case, which is
a balance between target coverage and normal structure
sparing. Typically, the spinal cord sparing is critical for
most H and N cases; therefore, a vertebral body is generally
a good choice as a reference ROI for alignment. For an
oropharyngeal cancer case, a high cervical (C1–C3) vertebral
body is a reasonable choice (Figure 5). Although a PTV
can be used in particular cases, one should be cautious
using GTV as an alignment target since asymmetric tumor
shrinkage can aﬀect the geographic relationship of GTV to
isocenter and avoidance structures.
5.2. Anticipated Workflow for Image-Guided Adaptive Radio-
therapy. In contrast to image-guided setup for repositioning
treatment fields, the intent of ART is to appropriately modify
Figure 2.1: Anatomic changes can be pronounced during treatment. In this
example, planning CT scan and CTV c ntours are shown on the
left. On the right, a mid-course CT (three weeks into treatment)
demonstrates signiﬁcant reduction in gross tumour (thick red line).
Baseline CTVs have been overlaid via rigid image registration.
These match current anatomy poorly and in fact extend past the
skin contour into air. Reprinted from Schwartz et al. 2011 with
permission.
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2.1 Library planning
Depending on tumour site, daily changes in anatomy may primarily be due to
diﬀerent levels of organ ﬁlling and organ motion. The bladder changes shape
and volume dependent on ﬁlling. Furthermore, variations in rectal volume cause
displacement of the bladder. In order to achieve a consistent bladder volume,
the patient will usually be asked to void before each fraction delivery. Despite
attempts to control bladder volume, signiﬁcant interfraction changes have been
documented (Turner et al. 1997; Fokdal et al. 2004). For bladder cancer, a 'plan
of the day' or 'library of plans' approach has been investigated by e.g. Burridge
et al. 2006; Chai et al. 2010; Murthy et al. 2011; Meijer et al. 2012. A 'library
of plans' is created ahead of treatment and the most appropriate plan from the
library is chosen prior to the delivery of each fraction, based on daily imaging.
Burridge et al. 2006 created three plans with diverse margins in the superior
direction. They chose the best plan based on daily CBCT scans. The average
small bowel volume that could be spared by choosing between the three plans
was 31± 23 cm3.
Murthy et al. 2011 created 6 plans based on an empty bladder planning CT
scan. The plans used 6 diﬀerent isotropic PTV margins. Figure 2.2 shows one
example of a planning CT with isotropic margins.
Meijer et al. 2012 acquired two planning CT scans, one with empty bladder and
one with full bladder. The GTV was delineated in both scans and from these, 3
additional GTV volumes were created by interpolation and one by extrapolation.
Prior to delivery of a fraction, the most appropriate plan was selected according
to the bladder shape, based on CBCT imaging. The authors conclude that a
highly conformal dose distribution was delivered to all bladder cancer patients
with promising clinical results. Figure 2.3 shows a daily CBCT scan with the
library of 6 GTV contours overlayed.
Chai et al. 2010 modelled patient-speciﬁc bladder deformation patterns from the
ﬁrst ﬁve daily CBCT scans performed during fractionated radiotherapy (RT)
employing principal component analysis (PCA). They conclude that their stat-
istical shape based segmentation approach robustly handles the relatively poor
CBCT image quality and allows for fast and reliable automatic segmentation of
the bladder for selection of the appropriate plan from the library of plans.
The beneﬁt of the library planning approach is that all plans can be prepared in
advance. When comparing Figure 2.2 and 2.3 described above it is clear that a
library of plans should be tailored for each individual patient whenever possible
as a library of isotropic margins does not describe the range of anatomical vari-
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by the Institutional Review Board and all patients were consented
before enrolment. From August 2008, 10 suitable patients (9 male
1 female) were enrolled and underwent treatment in the ﬁrst
phase of this ongoing protocol (www.ctri.in, CTRI/2009/091/
000559). The anisotropic PTV margins generated from this study
are being used in the next phase of the protocol, which also in-
cludes the treatment of the pelvic nodes.
Inclusion criteria were age >18 years, T2b–T4 (UICC 2002) histo-
logically proven transitional cell carcinoma without nodal or dis-
tant metastasis, absence of hydronephrosis and suitability for
bladder preservation. Patients had a maximal safe tumour resec-
tion and a cystoscopic bladder map was always available. Concur-
rent chemotherapy was given with weekly Cisplatin (30 mg/m2)
and one patient received 2 cycles of neoadjuvant chemotherapy
(Gemcitabine and Carboplatin). Acute urinary and bowel toxicities
were recorded in the RTOG scale. All patients underwent 3-
monthly cystoscopy, chest X-ray and urine cytology on follow-up.
The adaptive radiotherapy (ART) technique
This technique entailed the generation of six isotropic PTVs for
each patient at the time of planning and thus the generation of six
separate IMRT plans for each patient. All patients were treated on
helical tomotherapy and daily MVCT image guidance scans were
used to correct for patient positioning errors and to choose the
most appropriate PTV, depending on the shape, size and position
of the bladder on that day.
Planning CT scan
Patients underwent a planning CT scan in the supine position
with a knee rest and anterior and lateral ﬁducials. Non-contrast
scanswere taken fromtheumbilicus to5 cmbelowthe ischial tuber-
osity, with 3 mm slice thickness. The decision to treat on a full blad-
der or an empty bladder was based on the need for boosting the
tumour bed. Patientswith a solitary tumour or two tumours in close
proximity were deemed suitable for a simultaneous integrated
boost (SIB) andwere treatedwith a full bladder. A full bladderwould
facilitate better identiﬁcation of the tumour bed and minimise the
volume of normal bladder receiving a higher dose. These patients
followed a bladder ﬁlling protocol which involved voiding and then
drinking 400 ml of water, 30 min before the planning CT scan.
Patients not suitable for SIB, due to multiple tumours or presence
of carcinoma in situ, underwent a planning CT scan with an empty
bladder and were asked to void just before their treatment.
Contouring
The whole bladder was delineated as the CTV and six PTVs were
grown by giving isotropic margins from 5 mm to 30 mm, in steps
of 5 mm (Fig. 1). If the patient was eligible for an SIB, a CTV boost
volume was contoured, consisting of the tumour bed, any visible
tumour and suspicious areas based on its visibility in the planning
CT scan, as well as information from the cystoscopy bladder map
and diagnostic imaging. The CTV boost volume was given a uni-
form 10 mm margin to generate a PTV boost volume. The rectum,
bowel and femoral heads were contoured as organs at risk (OAR).
The pelvic nodes were not prophylactically irradiated for this
phase of the study.
Treatment planning
Treatment planning was done on the proprietary Tomotherapy
Planning Station (Ver.3.1.5.3). Six IMRT plans were generated for
each patient (one for each PTV). The prescription dose planned
for the bladder PTVs was 64 Gy/32# (2 Gy/#) and in cases with
SIB, PTV boost was planned for 68 Gy/32# (2.13 Gy/#). The 2 Gy
equivalent dose (EQD2) for the boost volume was 69.7 Gy for late
effects (a/b = 3) and 68.7 Gy for tumour kill (a/b = 10). The OAR
constraints deﬁned by RTOG P-0126 were met.
MVCT scanning and registration
For each treatment fraction, a pre and a post treatment MVCT
scan was taken. Pretreatment MVCT was co-registered with plan-
ning KVCT scan using automatic fusion of the bony anatomy
(Fig. 2a). The translational shifts (lateral, longitudinal and vertical)
and rotational variations (pitch, roll and yaw) were recorded. After
the automatic ‘bone-match’, the co-registration was manually ad-
justed so that the bladder ﬁt into the smallest of the six PTVs (plan
of the day), depending on the bladder size, position and shape
(Fig. 2b). This manual positioning (‘bladder-match’) accounted for
the deformation and displacement of the bladder for that fraction.
The selected ‘plan of the day’ and the ﬁnal applied corrections were
recorded.
It was ensured that the selected PTV encompassed the bladder
with at least a clear, visible 2–3 mm margin to account for poten-
tial intra-fraction bladder ﬁlling and imaging uncertainty. Action
levels were deﬁned for pitch and yaw as >2, as tomotherapy
cannot correct for these rotations. Grossly abnormal bladder
Fig. 1. Planning CT scan in axial, coronal and sagittal planes with six isotropic PTV
margins.
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Figure 2.2: Plan ing CT scan in axial, coronal and sagittal planes with six
isotropic PT margi s. Reprinted from Murthy et al. 2011 with
per ission.
the amount of water to drink was regularly adapted during treat-
ment in order to maximize the bladder content while still not
being too discomforting.
All patients were treated at an Elekta Synergy accelerator. After
setting up the patient to the skin markers the following setup cor-
rection and plan selection procedure was performed. First a cone
beam CT was acquired and the bony anatomy was registered to
the (full bladder) planning CT scan in the XVI software (Fig. 1a).
Secondly, the planning CT data were turned off while the six blad-
der contours were switched on and projected at the CBCT data
(Fig. 1b). Next, the most appropria e plan was selected based on
the best ﬁtting bladder contour in relation to the bladder shape
of the day. Subsequently all non-corresponding bladder volumes
were swit hed off and the corresponding GTV volume was turned
on after w ich the registration was manually tuned in order that
the selected GTV contours were matched with the anatomy in
the CBCT (Fig. 1c). Matching of the GTV was facilitated by the
lipiodol markers in the CBCT image. After the GTV registration
the plan selection was reassessed and adapted whenever
appropriate. Additionally, it was veriﬁed that the 95% isodose
surface of the selected plan encompassed the entire bladder in
all directions (Fig 1d). Finally, the setup correction was executed
and the appropriate plan was selected and the treatment started.
Dose warping
Dose warping techniques were used to illustrate the dosimetric
impact of this library planning approach in comparison to a con-
ventional single-plan approach. A single patient was selected that
showed substantial differences in bladder ﬁlling both at the CT
sca ning procedure and during treatment. For this patient the ac-
tual delivered dos was recomputed on the CBCT data for ﬁve frac-
tions with increasing bladder volumes for which plan 1 up to plan
5 were selected during treatment. Subsequently, mesh structures
of the bladder and GTV in the planning CTs were propagated to
the CBCTs and carefully adapted to the corresponding anatomy.
The recomputed CBCT dose distributions were deformed in Pinna-
cle 8.1y using an elastic body s line surface-model based image
registrati n tec nique and accumulated and projected at the full
and empty bladder planning CTs [19,20]. This exercise was then re-
peated for the conventional single plan strategies.
Follow-up
Response was assessed cystoscopically 4 months after treat-
ment completion, with subsequent cystoscopic follow-up at 6-
month ntervals. A local recurrence was deﬁned as the presence
of any visualized abnormality in combination with histological evi-
dence of malignancy within the bladder. Toxicity data were re-
corded using the CTCAE v4.0 toxicity scoring system on the ﬁnal
treatment day and at every follow-up visit.
Results
Patient characteristics
Twenty male patients have been treated in the period from Sep-
tember 2008 to September 2011. Female patients were not princi-
pally excluded from the protocol but the cohort in this study did
not include women. Reasons were the low prevalence within wo-
men and the limited ability of female patients for holding their ur-
ine. The median age was 82 years and ranged from 67 to 98.
Tumour stages varied between T2 (17 patients), T3 (two patients)
and T4 (one patient). One patient had a bladder diverticulum (as no
constraints were imposed to the regularity of bladder shape), but
this did not affect the protocol. All patients were able to follow
the drinking and voiding instructions but it turned out that the
bladder capacities varied considerably between individual pa-
tients. The maximum bladder volume varied between 143 and
704 cm3 whereas the minimum bladder volume varied between
57 and 317 cm3. The ratio between the full and empty bladder vol-
ume was on average 2.6 (range 1.6–4.7).
Lipiodol injections, CT scanning procedure and planning
Due to the ﬂuoroscopy guidance, sparse amounts of lipiodol
were injected that could easily be recognized at CT and CBCT with-
out showing artefacts. The markers were accurately placed in the
majority of patients. In six patients with tumours close to the blad-
der neck it was not possible to accurately mark the entire border of
the tumour due to the restricted ﬂexibility of the scope. The offsets
were observed, documented and taken into account in the delinea-
tion process by the radiation oncologist. The entire outpatient
procedure on average took 30 min and was well tolerated by all
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Fig. 1. Coronal and axial images of the treatment procedure: (a) automatic bone registration (purple planning CT, green CBCT), (b) plan selection based on bladder volume at
CBCT, (c) manual registration of the GTV using lipiodol markers, (d) target coverage veriﬁcation.
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Figure 2.3: Coronal and axial images of he treatment procedure: (a) auto-
matic bone registration (purple planning CT, green CBCT), (b)
plan selection based on bladder volume at CBCT, (c) manual re-
gistration of the GTV using lipiodol markers, (d) target coverage
veriﬁcation. Reprinted from Meijer et al. 2012 with permission.
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Fig. 3. Median skin contours at levels of C2 and base of skull compared with patient weight during radiotherapy course.
All data presented as fraction of initial single-slice contour volume or weight (Spearman two-tailed correlation
coefficient 0.917 for weight and contour volume at C2 [p 0.001] and 0.936 for weight and contour at base of skull [p
0.001]).
Fig. 4. Gross tumor volume changes over time among patients with head-and-neck cancer (HNn). Both (a,b) primary
tumor and (c,d) lymph nodes 2 cm3 in volume showed similar trend. Gross tumor volumes decreased at a median rate
of 0.2 cm3 or 1.8% of initial volume/treatment day.
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Figure 2.4: Primary tumour response to radiotherapy for HNCA patients ex-
pressed as GTV volume changes over time. All volume changes
follow a similar trend. GTVs decreased at a median rate of 0.2
cm3 or 1.8% of initial volume per day of treatment. Reprinted
from Barker et al. 2004 with permission.
ations particularly well. However, any library of plans might not accommodate
all anatomical variations encountered during treatment.
2.2 Radiation induced tumour volume changes
In addition to daily anatomical variations of OAR, tumours exhibit volume
changes to a varying degree during the course of radiotherapy. This is partic-
ularly true in head and neck, lymphoma and gynaecological cancers (Barker
et al. 2004; Girinsky et al. 2006; Yahalom 2005; Lim et al. 2008; Mayr et al.
2010). For a study including HNCA patients, Barker et al. 2004 showed that
gross tumour volumes decreased at a median range of 0.2 cm3 per treatment
day, with volume changes ranging between 0.01-2.0 cm3/day, corresponding to a
relative change of 1.8% of the initial volume per day. The median total tumour
volume change was 70%, ranging between 9.9 − 92%. The median centre of
volume displacement was 3.3 mm, ranging between 0-17 mm. Figure 2.4 shows
the volume response curves for GTVs and lymph nodes > 2cm 3 in volume.
Looney et al. 1975; Kovacs et al. 1976 demonstrated that following irradiation,
the growth rate of tumours is approximately linear (and negative) on a logar-
ithmic scale, after an initial delay in response.
The consequence of maintaining a large initial PTV throughout treatment, when
tumour volume changes are signiﬁcant, is that normal tissue and potentially
OAR might be irradiated with high dose.
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For example, the quadratic transformation model is defined by second
order polynomials
(13.2)
whose coefficients determine the 30 degrees of freedom of the transforma-
tion. In a similar fashion this model can be extended to higher order polyno-
mials such as third (60 DOF), fourth (105 DOF), and fifth-order polynomials
(168 DOF).
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 However, their ability to recover anatomical shape variability is
often quite limited since they can model only global shape changes and cannot
accommodate local shape changes. In addition, higher order polynomials
tend to introduce artifacts such as oscillations;
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 therefore, they are rarely used
for nonrigid registration.
 
13.2.1 Registration Using Basis Functions
 
Instead of using a polynomial as a linear combination of higher order terms,
one can use a linear combination of basis functions 
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i
 
 to describe the defor-
mation field:
(13.3)
A common choice is to represent the deformation field using a set of (orthonor-
mal) basis functions such as Fourier (trigonometric) basis functions
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 or wavelet
 
FIGURE 13.1
 
Example of different types of transformations of a square: (a) identity transformation,
(b) rigid transformation, (c) affine transformation, and (d) nonrigid transformation.
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Figure 2.5: (a) Identity transformation. (b) Rigid transformation. (c) Aﬃne
transformation. (d) Deformable transformation. Reprinted from
Hajnal et al. 2010 with permission.
2.3 Deformable intrasubject image registration
The concept of deformable image registration (DIR) is important to the ﬁeld of
adaptive radiotherapy (ART). Most protocols for adaptation of the treatment
plan rely on it. DIR can be used to determine a non-rigid spatial transformation
that establishes meaningful correspondence between images of a patient acquired
at diﬀerent points in time and/or acquired with diﬀerent imaging modalities.
In DIR, a target image T is deformed by a transformation φ in order to satisfy
an objective function that maximises similarity with a reference image R. This
is often achieved by ﬁnding the transformation that minimises a dissimilarity
measure D between R and the transformed target image T ◦ φ as
min
φ
(D(R, T ◦ φ) +R(φ)) , (2.1)
where R is a regularisation term, penalising transformations that are for one
reason or the other unlikely.
The transformation is a deformation ﬁeld of vectors that for each pixel/voxel in
the reference image map to the corresponding point in the target image. As most
images used in radiotherapy are three dimensional, the deformation ﬁeld is three
dimensional as well. A CT or MRI scan can easily hold 512×512×200 = 52.4·106
voxels. As each deformation vector itself is three dimensional, the total number
of estimated parameters would in this case be 157 · 106.
(Hajnal et al. 2010)
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2.3.1 Parametric transformation models
Direct optimisation of the image registration problem is ill-posed due to the
number of estimated parameters. Instead of direct optimisation of the dense
deformation ﬁeld, the transformation is often modelled by more compact de-
formation models with fewer parameters that employ interpolation to determ-
ine the dense deformation ﬁeld. Such models include, but are not limited to,
the free-form deformation (FFD) (b-spline) model (Rueckert et al. 1999), thin-
plate splines (Rohr et al. 2001), radial basis functions (Fornefett et al. 2001),
ﬁnite-element model (Xuan et al. 2006), and piece-wise linear transformations
(Arsigny et al. 2003).
2.3.2 Non-parametric transformation models
In addition to the parametric models, image registration can be non-parametrically
modelled. Horn et al. 1981 modelled registration using equations from physics
for motion of incompressible ﬂuids. Thirion 1998 modelled registration as a
diﬀusion process. This method is often called demons registration.
2.3.3 Objective functions
Feature-based objective functions aim to minimise the distance between land-
marks. An Euclidean distance measure is often employed. As both manual and
automatic landmark extraction in three-dimensional medical images is generally
non-trivial, feature-based objective functions are seldomly used for time critical
applications. (Joshi et al. 2000; Lowe 2004)
Intensity-based objective functions evaluate the intensity diﬀerence between the
reference image and the deformed target image. When registering images that
are acquired with the same imaging modality and are characterised by similar
intensity distributions, a normalised sum of absolute diﬀerences (SAD), sum
of squared diﬀerences (SSD) or normalised cross-correlation (NCC) objective
function can be suﬃcient (Hajnal et al. 2010). More computationally demanding
objective functions such as correlation ratio (Roche et al. 1998) and mutual
information (Wells et al. 1996; Maes et al. 1997) are suitable for registration of
images acquired with diﬀerent modalities.
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2.3.4 Regularisation
While the objective functions drives the registration process, it is often necessary
to add a regularisation term in order to constrain the resulting deformation
map and avoid undesirable characteristics. When modelling an intrasubject
anatomical change with deformable registration, a diﬀeomorphic deformation
ﬁeld is preferred, that is, a smooth, non-folding, invertible ﬁeld. This is often
achieved by constraining the ﬁrst derivative of the dense deformation ﬁeld. Local
rigidity can be achieved by imposing local orthogonality of the Jacobian matrix
(Loeckx et al. 2004). Volume preservation can be achieved by constraining the
determinant of the Jacobian matrix to unity (Rohlﬁng et al. 2003).
Biological studies have shown that biological tissue behaves similar to rubber.
That is, they are nearly incompressible and compliant to shear, see e.g. Hu
2006; Sarma et al. 2003. Regularisation that imposes a rubber-like deformation
prior is suitable for intrasubject image registration when images are acquired
temporally close. In radiation oncology, patients are likely to exhibit signiﬁcant
general weight loss as well as tumour shrinkage, local oedema and tissue loss in
proximity to the tumours during radiotherapy. These volume changes make use
of a strict incompressibility constraint unsuitable. Relaxing the incompressibil-
ity constraint transforms the rubber prior into a more general elasticity prior.
Linear elasticity matching (Broit 1981) has been widely used for image regis-
tration but the lack of local rotation invariance can hinder optimal matching.
Especially in HNCA imaging, the neck posture (bending in the neck) may cause
the linear elasticity prior to over-regularize the deformation. The Riemannian
elasticity prior is a simple weighted quadratic penalty on the Hencky strain
tensor which inherits local rotational invariance while the inﬁnity energy limit
approaches the black-hole deformation, signifying that collapsing tissue to an
inﬁnitesimally small volume takes inﬁnite energy (Pennec et al. 2005). Figure
2.6 illustrates the concept of rotational invariance. The local deformation can
be decomposed into an orthonormal tensor representing the rotation and a pos-
itive deﬁnite symmetric tensor representing the stretch. While biological tissue
is elastically anisotropic, anisotropic modeling requires many parameters which
cannot be estimated from CT scans alone. Assuming isotropic behaviour, the
number of parameters can be reduced to two; the usual Lamé parameters µ, λ.
The isotropic Riemannian elasticity is given as
Rrie(µ, λ;φ) = µ
4
N∑
i=1
log2 εi +
λ
8
(
N∑
i=1
log εi
)2
, (2.2)
where µ controls the amount of elastic potential due to shearing, and λ controls
the amount of elastic potential due to local compression or expansion. εi are the
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Figure 4.6: Polar decomposition of material deformation gradient tensor.Figure 2.6: Rotational invarian e illustrate . The local deformation can be
decomposed into an orthonormal tensor representing the rotation
and a positive deﬁnite symmetric tensor representing the stretch.
Reprinted from Hansen 2009 with permission.
principal stretches. In contrast to linear elasticity and Saint-Vernant Kirchoﬀ
elasticity λ is solely related to local volume change (Hansen 2009).
2.4 Treatment plan adaptations
Some tumours exhibit variations that are primarily due to permanent changes
in anatomy that cannot be predicted or planned for in advance. These include
tumour annihilation, general weight loss, oedema, etc.
Figure 2.7 shows a typical workﬂow for treatment plan adaptation. Either a
daily CT, CBCT or MRI scan is compared to the original planning scan. If
needed, the daily scan forms the basis for propagation of contours of the target
and OAR structures and subsequent treatment replanning to reﬂect the anatom-
ical changes. In the literature this regime is generally referred to as image-guided
radiation therapy (IGRT), although image guidance is used for treatment plan-
ning, patient setup as well as intrafraction guidance. The contour propagation
from the 3D planning scan to a replanning scan can be automated by establish-
ing correspondence between the images by means of image registration.
In short, replanning relies heavily on fast and accurate in-room imaging, fast
and reliable deformable image registration of the daily scan to the planning
scan, and fast treatment planning software.
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Figure 6: A workflow diagram for in-room CT or CBCT-guided adaptive radiotherapy. The first level of treatment modification is a simple
couch shift to correct for daily setup errors (CT-guided IGRT). Nonrigid changes in tumor volumes and normal organs can then be corrected
via an online or oﬄine adaptive replanning process (dotted lines).
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Figure 7: The ART process for patient treatment starts with a rigid alignment (in this example, to the C2 vertebra) between the reference
planning CT and the daily in-room CT ((a) and (b)). The planning contours are overlaid to the daily CT to verify setup accuracy and to
evaluate if there are changes in current anatomy relative to baseline. If the changes are significant, as illustrated in (b), a deformable image
registration can be performed to propagate original planning contours onto current anatomy. The resultant contours are shown on (c). This
process takes less than 30 seconds.
Figure 2.7: A workﬂow diagram for in-room CT or CBCT-guided adaptive
radiotherapy. The ﬁrst level of treatment modiﬁcation is a simple
couch shift to correct for daily setup errors (CT-guided IGRT).
Nonrigid changes in tumour volumes and normal organs can then
be corrected via an online or oine adaptive replanning process
(dotted lines). Reprinted from Schwartz et al. 2011 with permis-
sion.
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Figure 2.8 provides an example of deformable image registration with a Rieman-
nian elasticity prior of a planning and replanning CT scan for a HNCA case with
the purpose of automatic contour propagation. Contours propagated by deform-
able and rigid registration are compared to manual re-contouring. It can be seen
how the rigid structures do not line up after rigid registration. Contours propag-
ated using deformable registration resemble the manually propagated contours.
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Figure 2.8: Example of contour propagation using deformable image registra-
tion with a Riemannian elasticity prior for a HNCA patient (Bjerre
et al. 2012). (a) Planning CT scan with GTV contour (· · ·). (b)
Overlay of planning CT and rigidly registered replanning CT. (c)
Overlay of planning CT and deformably registered replanning CT.
(d) Replanning CT, rigidly registered to planning CT, with ori-
ginal contour. (e) Replanning CT with automatically adapted
GTV contour (-) and manual replanning contour (· · ·). (f) Jac-
obian determinant of the deformation ﬁeld. Blue colour signiﬁes
volume shrinkage, red volume expansion, green no volume change.
Mohan et al. 2005 suggested a method for treatment plan adaptations that mod-
iﬁes the beam shape and intensity according to the new position and shape of the
target and OARs without the use of traditional, time consuming replanning. A
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daily CT scan was acquired and the contours were propagated from the planning
CT. As this was a proof-of-concept study this was done manually, but would
ultimately have to be done using deformable image registration of the volume
images. The beam shape is modiﬁed according to the changes in target/OAR
position and shape on projections from the BEV. For deformable registration
of these 2D projection images they used the demons algorithm (Thirion 1998).
The authors state that for the investigated prostate and HNCA examples this
method yielded a good approximation of thorough replanning compared to other
alternatives.
Feng et al. 2006 suggested a technique that directly modiﬁes the MLC aperture
shape of each segment based on the 2D vectors orthogonal to the beam direction
generated by collapsing 3D deformation vectors along the beam line. The 3D
deformation ﬁeld was determined using a FFD registration method.
Ahunbay et al. 2008 suggested a technique that directly modiﬁes the MLC seg-
ment shape based on daily images to avoid full replanning. Daily CT images
were acquired using in-room CT-on-rails. A robust and semi-automatic tool
was employed for rapid modiﬁcation of PTV and OARs delineations to ﬁt new
location and shape of volumes. The beam shape was adjusted using a segment
aperture morphing (SAM) algorithm where MLC leaf shifts are calculated based
on the BEV of the original and new target projections. The segment weight for
the new apertures are optimised using a segment weight optimisation (SWO)
algorithm in order to optimise the dose distribution according to the plan ob-
jectives. The procedure took less than 10 minutes on a daily basis. The authors
conclude that the dose distribution as given by DVHs is comparable to that
achieved by thorough re-planning. Compared with the technique suggested by
Mohan et al. 2005, this technique directly adjusts beam/segment shapes. Using
the same method but with MIMVISTA deformable image registration software
for contour propagation, Ahunbay et al. 2009 carried out a study including
HNCA patients.
As most of this research is still in a proof-of-principle stage, there are few studies
providing statistics on the eﬀect of introducing ART techniques in the clinic. For
113 breast tumour patients, Hurkmans et al. 2012 performed a replanning scan
10 days into the treatment. By means of replanning, the volume receiving more
than 95% of the boost dose could be reduced by 19%. The authors observed no
changes in mean dose to the heart. They concluded that the procedure proved
to be eﬃcient and eﬀective, leading to a clinically signiﬁcant reduction of the
high dose volume.
Schwartz et al. 2011 performed daily automated replanning of 22 HNCA pa-
tients. Their preliminary clinical outcomes document functional recovery and
preservation of disease control at 1-year follow-up.
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While recent research has been focused on reducing the time spent on contour
propagation and treatment replanning by means of approximative methods, the
advances in computational power as well as code optimisation and parallelisation
might eventually close the gap to thorough replanning. It is notable that there
is an apparent lack of studies comparing the accuracy of emerging commercial
solutions (that are often 'black box' methods) and techniques described in the
literature.
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Chapter 3
Intrafraction motion
management
In addition to daily changes, some sites of cancer are susceptible to signiﬁcant in-
trafraction changes in anatomy. In addition to patient motion on the treatment
table due to pain and/or anxiety, the abdominal and thoracic organs exhibit
periodic anatomical changes caused by respiratory and cardiac motion (Bort-
feld et al. 2004). In a review of 20 liver cancer patients, Kitamura et al. 2003
documented [4± 4, 9± 5, 5± 3] mm tumour motion amplitude in the left-right,
craniocaudal and anterior-posterior direction respectively. For 54 renal cancer
patients, van Sörnsen de Koste et al. 2006 reported predominantly craniocaudial
motion. Mean motion was 9.8 mm for left kidney and 9.0 mm for the right, with
maximum excursions of 30 and 20 mm respectively.
Respiratory tumour motion can be accounted for by means of patient-speciﬁc
target margins based on 4D planning CT scans. 4D CT scans are comprised of
3D CT images at discrete phases of the respiratory cycle. It can be achieved
by binning projections based on an external respiratory signal (Vedam et al.
2003a). Through detection of mid-ventilation tumour position and oscillation
pattern the PTV margins can be reduced (Wolthaus et al. 2008; Hughes et al.
2008; Korreman et al. 2012; Aznar et al. 2013).
Alternatively, motion can be directly accounted for through the use of gating-
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based or motion compensating methods, the purpose being to further reduce
target margins.
This chapter describes approaches and technologies to support intrafraction mo-
tion management.
3.1 Marker-based motion management
Ideally, in order to compensate for intrafraction tumour and OAR motion and
deformation, soft tissue tracking based on real-time volume imaging should be
applied. This is, however, not feasible using X-ray based imaging. Thus, motion
tracking based on implantable and external markers is the current state of the
art when it comes to intrafraction motion compensation. Employing implantable
gold ﬁducial makers, 3D internal marker and thus tumour position and motion
can be determined from two orthogonal X-ray images. As constant X-ray im-
aging adds signiﬁcant dose to the patient these systems are normally not used
for constant tracking during treatment delivery. Markers on the outside of the
body can be used to monitor breathing motion as well. A correlation between
motion of the external marker and motion of the tumour can be established
by monitoring marker motion while acquiring 4D scans, in which the tumour
can subsequently be identiﬁed or by tracking an internal implantable ﬁducial
marker using conventional X-ray. As such these external markers function as
surrogates for tumour motion tracking. Figure 3.1 illustrates the conﬁguration
of X-ray sources and detectors used for motion tracking. (Seppenwoolde et al.
2007; Jin et al. 2008)
Marker-based motion tracking is readily available from commercial systems such
as the Accuray CyberKnife Synchrony Respiratory Tracking System (RTS) or
the BrainLab ExacTrac. The tracking accuracy of the CyberKnife system based
on external markers and x-ray veriﬁcation every 60 seconds is around 2 mm
(Seppenwoolde et al. 2007). The ExacTrac system oﬀers similar or slightly
better accuracy (Jin et al. 2008).
While the ExacTrac system oﬀers beam gating based on the respiratory sig-
nal, the CyberKnife system, based on a robotic arm linac enables motion com-
pensated delivery (Adler Jr et al. 1997; Adler Jr et al. 1999; Schweikard et
al. 2000; Chang et al. 2003). In beam gated delivery, the beam is switched
oﬀ when the tumour moves out of the beam ﬁeld. Using gated delivery it is
possible to reduce margins (Hugo et al. 2003; Korreman et al. 2008) and es-
calate dose (Wagman et al. 2003), although Korreman et al. 2008 concluded
that margins can only be reduced if respiratory baseline shifts and variations
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Figure 3.1: The BrainLab ExacTrac system. The two X-ray sources can be
used for tracking an implanted gold ﬁducial marker. Image Cour-
tesy of BrainLab, Inc. All rights reserved.
in external/internal motion correlation are accounted for, for example by use of
respiratory correlated image guidance.
While beam gating is simpler than motion compensated delivery and might
oﬀer comparable accuracy, the total delivery time will be prolonged for the
same beam-on time (Fox et al. 2007).
D'Souza et al. 2005 conducted experiments with a robotic couch, moving the
patient according to breathing pattern in other to keep tumour location constant
in relation to the linac. Besides being uncomfortable for the patients, such a
system might inﬂict additional patient motion in itself.
As an alternative to radiopaque markers and X-ray imaging, electromagnetic
(EM) transponders can be implanted near tumours and form the basis for low-
latency tumour tracking without need for additional ionizing radiation (Sawant
et al. 2009). Compared to the methods combining intermittent X-ray based
tracking of an internal marker and constant feedback from an external surrogate,
EM based systems provide constant feedback directly from the internal marker
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in real time.
Generally, use of implantable markers is undesirable as it is an invasive procedure
adding risk of infection, stress of the patient and additional labour. Often,
the marker is not implanted in the tumour itself, but in nearby soft tissue
due to the risk of spreading tumour cells during the procedure. During the
treatment, a marker might migrate in the tissue causing a changed relation to
tumour position. In addition, studies have reported poor correlation between
internal and external markers for some tumour sites. Feng et al. 2009 reported
poor correlation between the position of pancreatic tumours and the abdominal
wall when breathing, as well as substantial deformation of tumour borders.
For patients with lung tumours, Koch et al. 2004 reported good correlation
(0.87 ± 0.23) between lung-vessel motion in the superior-inferior direction and
poor correlation (0.44 ± 0.27) in the anterior-posterior direction. Signiﬁcant
intersubject variability was observed. The authors concluded that the motion
of an external ﬁducial may not correlate fully with, or predict, internal lung
motion.
Another general concern is that OAR motion might be uncorrelated or not
accounted for when adapting the ﬁeld based on tumour position alone. This
factor needs to be taken into consideration during planning.
4D planning scans can form the basis of a 4D treatment plan where tumour
position and shape are correlated to breathing phases as well as position of an
external marker (Vedam et al. 2003b). Keall et al. 2005 demonstrated how such
a 4D plan can be used for dynamic multileaf collimator (DMLC) based motion
tracking. DMLCs are dynamic in the sense that they can adapt treatment beam
shape during fraction delivery. A real-time external marker respiration signal
is fed to the DMLC controller and the DMLC is adjusted according to position
and shape for the corresponding breathing phase. To keep workload down, the
target contours were deﬁned on the end-inspiration CT image and deformed to
the remaining breathing cycle scans using deformable image registration. For
the test case they reported dose reductions for the spinal cord, heart and lungs.
If breathing pattern changes during treatment, 4D replanning might be indic-
ated. As weekly or daily 4D CT does add signiﬁcant dose to the patient, 4D
MRI might be more appropriate for that purpose, depending on tumour site as
well as availability.
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3.2 4D CT imaging and tomographic image re-
gistration
4D CT scans are normally acquired using conventional scanning hardware. Fan-
beam based CT scanners acquire one axial slice at a time. When acquiring and
reconstructing 4D scans, a number of axial slices are sequentially acquired for
each axial position and subsequently sorted into a limited number of breathing
phase bins. Inaccurate sorting might lead to tissue discontinuity artifacts in
the reconstructed CT volumes. This is especially seen at mid-inspiration or
mid-expiration phases (Zeng et al. 2007).
Lyksborg et al. 2010 estimated a CT reference volume as well as a 4D B-spline
deformation ﬁeld using an optimisation method that included scan re-binning
estimation.
Zeng et al. 2007 proposed to model motion, based on CBCT projections, as
deformation of a prior 3D CT scan. Using this deformation from orbiting
views (DOM) method, motion is modelled from slowly rotating X-ray cone-beam
projection views and not through the use of markers. A breath-hold CT scan
is deformed using a B-spline deformation model in order to optimise similarity
between modeled projection views of the deformed volume and actual projec-
tions acquired at diﬀerent breathing cycles. An advantage over traditional 4D
CT is that discontinuity artifacts are avoided since correlation between internal
anatomy and position of an external marker is not assumed.
However, the development in CT scanner hardware, with the recent advent of
scanners with 320 detector rows, 16 cm axial coverage and 0.275 second rotation
time is likely to reduce this particular kind of artefact.
Sarrut et al. 2006a proposed to acquire only inhale and exhale breath-hold scans
and simulate intermediary breathing phase volumes by deformable image regis-
tration of the breath-hold scans with subsequent vector ﬁeld interpolation. The
beneﬁt of this approach is reduced imaging dose, compared to acquiring all axial
slices at all breathing phases. As motion during acquisition is limited during
breath-hold, motion blurring should be reduced compared to free breathing ac-
quisition. If the 4D scan is to be used for planning of DMLC based delivery one
disadvantage of this approach is the lack of correspondence between simulated
breathing phase anatomy and the position of an external marker. The same
holds for the DOM reconstruction method.
Li et al. 2011 demonstrated that low-latency 3D tumour localisation based on
single CBCT projections is possible. Deformation vector ﬁelds between a ref-
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erence breathing phase and other breathing phases can be represented by a
few eigenvectors and coeﬃcients obtained by PCA. Now, for each acquired
cone-beam projection, PCA coeﬃcients are estimated that correspond to a de-
formation of the 3D volume producing a computed projection similar to the
actual projection. The disadvantage of this method might be limited modelling
capability when encountering motion patterns not previously experienced.
3.3 MRI low-latency guidance
In recent years, integrated MRI-radiotherapy systems have been developed as
described in Section 1.4.3. These systems oﬀer fast intrafraction imaging suit-
able for both beam gating (Crijns et al. 2011) and motion compensation (Ries
et al. 2010; Cerviño et al. 2011; Crijns et al. 2012; Yun et al. 2012b; Yun et al.
2012a).
For tumour tracking, acquisition of high-quality live 3D images and subsequent
low-latency DIR would be optimal. This is currently not feasible due to the lack
of appropriate MRI acquisition sequences and DIR algorithms.
Crijns et al. 2012 tracked 1D motion using a DMLC equipped MRI-linac proto-
type. Motion tracking was based on edge detection on pencil-beam navigators
Stam et al. 2012. This work primarily aims to prove that fast imaging, motion
detection and DMLC control for motion compensated delivery is possible using
MRI-linac systems.
Cerviño et al. 2011 suggested the use of template matching for real-time lung
tumour tracking in sagittal cine-MRI scans. An inherent drawback of tracking a
3D structure in a 2D plane is the inability to detect out-of-plane motion. They
suggest addressing out-of-plane motion by surrogate tracking of the diaphragm.
Yun et al. 2012b investigated the use of an intra-fractional lung tumour auto-
contouring algorithm for a phantom study using sagittal cine-MRI planes. Yun
et al. 2012a describes how the auto-contouring algorithm of Yun et al. 2012b can
be extended with an artiﬁcial neural network (ANN)-based motion prediction
algorithm.
Ries et al. 2010 performed 3D target tracking by combining 2D-plane imaging
with prospective slice tracking based on pencil-beam navigator sequences. The
eﬀect of the update latency was reduced using a Kalman-predictor for trajectory
anticipation. One limitation they ﬁnd is that since the detected beam signal is
predominantly spin-density weighted, it suﬀers from poor tissue contrast, which
can potentially lead to poor tracking performance.
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In the future, MRI-radiotherapy systems could facilitate non-invasive, non-
surrogate based, low-latency tumour motion tracking with no additional im-
aging radiation dose. While 'real-time' deformation in a 2D plane could be
determined, such information will in many cases be of limited value due to the
unknown out-of-plane deformation. Information on 3D deformation can not be
achieved directly due to current limitations in hardware and/or lack of appro-
priate MRI sequences. It might be possible to model lung deformation using
PCA and infer 3D deformation in a fashion similar to that described by Li et al.
2011 for cone-beam projections.
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Chapters 6, 7, 8 and 9 present selected peer-reviewed contributions. They are
all re-formatted according to the template of this thesis and are available in
original form online and in print.
In the following, introductions to these select contributions are given.
Modeling tumor size and density changes during chemora-
diation therapy for head and neck cancer
The purpose of this work was to investigate changes in total GTV volume and
density for 10 HNCA patients during IGRT. For the investigated tumours,
changes in logarithmic volume were described well by a linear function with
patient-speciﬁc slope and intercept. While changes in GTV volume have previ-
ously been documented, changes in GTV density have not. Changes in density
were well described by a linear function with patient-speciﬁc slope and inter-
cept. Density changes are relevant as delivered dose to a tissue and calculated
dose distributions rely on density. Furthermore, tumour density changes might
be indicative of treatment response in the same sense as volume changes are.
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Spatially Varying Riemannian Elasticity Regularization: Ap-
plication to Thoracic CT Registration in Image-Guided Radio-
therapy
This work explores how spatially varying elasticity parameters can be employed
in image registration in order to encourage bone rigidity and local tissue volume
change only in the GTV and the lungs. This is highly relevant for image regis-
tration in ART, especially when modelling signiﬁcant tumour volume changes.
Demons Registration of CT Volume and CBCT Projections
for Adaptive Radiotherapy: Avoiding CBCT Reconstruc-
tion
This work is related to research described in Section 3.2. CBCT quality is
usually sub-par to that of CT. As such, it is feasible to model the CBCT recon-
struction as a deformation of a planning CT of the same patient. Previous eﬀorts
have employed B-spline deformation models. Here, a non-parametric diﬀusion
based deformation model is employed as a proof-of-concept. This opens the
door to the use of more advanced non-parametric image registration algorithms
such as diﬀeomorphic demons (Vercauteren et al. 2009) or the use of special-
ised anisotropic regularisation for modelling sliding organs (Pace et al. 2011).
The described framework employs a parallel implementation of the forward- and
back-projector described by Long et al. 2010.
A signiﬁcant advantage of modelling the CBCT reconstruction as a deformation
of a planning CT, is that no sub-sequent image registration is needed in order
to obtain the deformation which can subsequently be employed for contour
propagation in ART.
Three-dimensional MRI-linac intrafraction guidance using
multiple orthogonal cine-MRI planes
This work is related to intrafraction image guidance with MRI-radiotherapy
devices. As these devices oﬀer close to real-time imaging without any addi-
tional ionising radiation to the patient, constant image-based guidance is pos-
sible without any undesirable eﬀects for patients. An added beneﬁt of MRI
based tracking is that it is possible without the need for implanting ﬁducial
markers.
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Previous research on this topic has demonstrated how single plane cine-MRI can
be used for tumour tracking. Here, it is demonstrated how multiple, orthogonal
slices can form the basis for reliable 3D soft tissue tracking.
Chapter 5
Discussion and conclusion
As anatomical and functional imaging of tumours improve, so does our investiga-
tion into adaptive radiotherapy planning and intrafraction motion management.
Both techniques allow for reduced treatment margins and dose escalation to the
target volume. Improved image-guidance is the necessary basis for increases in
TCP and reductions in NTCP.
This thesis presents selected contributions with applications in support of robust
CT and CBCT based treatment replanning and real-time MRI based intrafrac-
tion guidance.
In the contribution titled "Modeling Tumor Size and Density Changes in Head
and Neck Cancer during Treatment with IGRT", it is shown that changes in
tumour density were well described by linear function with patient-speciﬁc slope
and intercept, for ten head & neck cancer (HNCA) patients. This might be of
particular interest for proton therapy as delivered dose to a tissue and calculated
dose distributions rely on density. Furthermore, tumour density changes might
be indicative of treatment response.
In the contribution titled "Spatially Varying Riemannian Elasticity Regulariz-
ation:
Application to Thoracic CT Registration in Image-Guided Radiotherapy", it is
demonstrated how spatially varying elasticity parameters can be employed in
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image registration to encourage bone rigidity and local tissue volume change
only in the GTV and the lungs. This is highly relevant in adaptive radiothe-
rapy (ART) when modelling signiﬁcant tumour volume changes. While the
results were promising, one concern is that additional modelling parameters are
introduced which need to be optimised.
In the contribution titled "Demons Registration of CT Volume and CBCT
Projections for Adaptive Radiotherapy: Avoiding CBCT Reconstruction", it
is described how CBCT reconstruction can be modelled as a deformation of a
planning CT scan of the same patient, using a non-parametric diﬀusion based
deformation model, opening the door to the use of a number of advanced non-
parametric algorithms. An advantage of reconstruction by deformation is that
no additional image registration is needed in order to obtain the deformation
which can subsequently be employed for contour propagation in ART.
In the contribution titled "Three-dimensional MRI-linac intra-fraction guid-
ance using multiple orthogonal cine-MRI planes", it is demonstrated how MRI-
radiotherapy devices have the potential to oﬀer near real-time intrafraction im-
aging without any additional ionising radiation. It is detailed how the use of
multiple, orthogonal slices can form the basis for reliable 3D soft tissue track-
ing. An important limitation of this method is that local rigidity is assumed. As
such, the method does not account for any deformations, nor will it be possible
without intrafraction volume imaging. This, however, is true for all intrafrac-
tion tracking methods that do not model deformation based on prior volume
imaging.
For large-scale treatment plan adaptation to be feasible, in-room imaging, im-
age registration, and replanning procedures need to be both fast and robust. In
reality, these qualities are often contradictory and the greatest challenges are to
secure reliable contour propagation and high quality replanning while keeping
preparation time down in order to minimise patient discomfort and maxim-
ise clinical eﬃciency. With the advent of comparatively inexpensive CPU/GPU
scientiﬁc computing clusters, implementation and clinical use of robust but com-
putationally expensive algorithms might be feasible in the near future. Parallel
programming is still an evolving ﬁeld that is highly likely to provide signiﬁcant
contributions before long.
In recent years eﬀort has been increased in the ﬁeld of intrafraction guidance.
Commercial systems based on tracking of internal and external markers are read-
ily available but research into next generation devices and systems is ongoing.
Currently, MRI guidance seem to be the next logical evolutionary step in the
pursuit of real-time image-based guidance, as it has the potential to enable con-
stant image-based target tracking without subjecting the patient to additional
ionizing radiation.
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Chapter 6
Modeling tumor size and
density changes during
chemoradiation therapy for
head and neck cancer
T. Bjerre, K. Conradsen, M. Aznar, P. Munck af Rosenschöld, L. Specht, R.
Larsen. 'Modeling tumor size and density changes during chemoradiation ther-
apy for head and neck cancer'. In: Submitted.
Abstract
Introduction: We analyze and model changes in tumor radiodensity as well
as tumor size for ten head and neck cancer patients during their course of treat-
ment based on PET/CT planning scans and CT replanning scans. Methods:
We compare (up to) second order polynomial regression models for repeated
measurements with patient speciﬁc as well as population speciﬁc parameters.
Results: For the patients included in this study, changes in both tumor size
and radiodensity were well described with linear regression models with patient
speciﬁc bias and slope. Conclusions: Signiﬁcant changes in both volume and
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radiodensity were observed. In addition to tumor volume changes, tumor ra-
diodensity changes might need to be taken into account if/when re-planning
patients in adaptive photon radiotherapy and could be of substantial import-
ance in adaptive proton therapy as dose distributions are highly dependent on
changes in tissue density.
6.1 Introduction
Image-guided intensity-modulated radiation therapy (IG-IMRT) planning often
relies on both anatomical and functional imaging. In fractionated radiotherapy,
a patient's treatment course may span up to 8 weeks. Image-guidance is typ-
ically employed during the treatment course to position the patient according
to their treatment planning PET-CT scan in eﬀort to avoid changes to the
prescribed dose distribution. Exact positioning, however, may not account for
possible interfraction changes in the anatomy, including general weight loss, tu-
mor shrinkage/progression, oedema, bladder ﬁlling, bowel peristalsis, etc. These
changes are traditionally accounted for by adding appropriate margins to the
target volume. Wider margins ensure that the prescribed dose is delivered to
the intended volume but also inevitably increases dose to organs at risk (OAR),
thereby increasing the normal-tissue complication probability (NTCP). (Verel-
len et al. 2007)
Regular interfraction treatment plan adaptations can be used to improve target
accuracy, and thereby increase conformality by minimizing the use of margins.
Treatment plan adaptation can occur on diﬀerent time-scales: real-time to ac-
count for acute changes such as breathing motion, and periodic to account for
more gradual changes such as weight loss.
Patients are typically positioned on the treatment table using laser guidance
based on external anatomy. Image-guidance is then used to verify the in-
ternal anatomy. For this purpose, 2D transmission scans acquired using the
onboard cone-beam CT (CBCT) scanner are co-registered to the planning CT
scan. While reconstructed 3D CBCT scans oﬀer information about anatomical
changes they are often not easily co-registered to CT scans for direct comparison
as they do not provide the same image contrast, and often have beam-hardening,
metal or motion artifacts. Ding et al. 2007 concluded that CBCT images are
suitable for analyzing signiﬁcant changes in anatomy and determine dosimet-
ric consequences for photon radiation therapy, while it is a challenging task to
accurately delineate tumor and organs using CBCT images due to the image
quality. Additional planning CT may be necessary to perform IMRT re-planning
at present in order to accurately delineate tumor and organs.
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In head and neck cancer (HNCA) it is critical to minimize margins in order to
spare nearby OAR. Most important to spare is the spinal cord, which should be
kept below 50 Gy. Other organs important for the patientsâ¿ quality of life
are the parotid and the submandibular salivary glands, which should be kept
below a mean dose of 26 and 46 Gy, respectively. The mandible, the constrictor
muscles of the pharynx, and the larynx are also important organs to spare.
Tumor size, but not density, is a response evaluation criterion in solid tumors
(RECIST). However, when tumor tissue responds and becomes necrotic, the tu-
mor volume might be unchanged while the density changes. While some studies
have investigated tumor density changes during the course of chemotherapy
(Choi et al. 2004; Faivre et al. 2011), studies of systematic monitoring of dens-
ity changes during the course of (chemo)radiotherapy have not been performed
to our knowledge. Knowledge about tumor density changes during radiotherapy
might be valuable for treatment monitoring. Furthermore, signiﬁcant tissue at-
tenuation changes might inﬂuence adaptive treatment planning.
In this study we analyze and model changes in tumor size as well as tumor
(radio)density for ten HNCA patients during their course of treatment. We
base our observations on CT scans acquired regularly during the course of the
treatment as true Hounsﬁeld unit (HU) values are needed to study density
changes.
6.2 Methods
6.2.1 Data
This study includes ten HNCA patients: three oropharyngeal cancers (patients
1,4,6), two oral cavity cancers (patients 2, 7), two hypopharyngeal cancers (pa-
tients 3, 9), two laryngeal cancers (patients 8, ) and one cancer of unknown
primary (patient 5). All patients were treated with chemoradiotherapy.
For each patient, PET-CT planning scans were acquired as well as 2-4 re-
planning CT scans for each patient during the course of the treatment (14-39
days after ﬁrst fraction). For each patient the gross tumor volume (GTV) was
delineated on the planning PET-CT. The GTV delineations were subsequently
propagated from the planning CT to each re-planning CT using manual contour-
ing by an experienced radiation oncologist. Manual contouring was performed
by pasting the set of contours from the planning CTs onto the re-scans and sub-
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Figure 6.1: Delineated tumor volumes as a function of time during treatment
sequently adapting them to reﬂect actual anatomical changes. For the planning
PET-CT scans, the delineated GTVs were between 83 and 311 cm3.
For each patient, Figure 6.1 shows the delineated tumor volume as a function of
time (days). The measured volumes are normalized by logarithmic transforma-
tion, in order to reduce the dependence on delineation accuracy that inherently
has greater inﬂuence on smaller volumes than larger ones. Furthermore, Looney
et al. 1975 and Kovacs et al. 1976 demonstrated that following irradiation, the
growth rate of tumors is approximately linear (and negative) on a logarithmic
scale, after an initial delay in response. Figure 6.2 shows the logarithmic tumor
volumes as a function of time.
Preliminary investigations showed that the histogram of HU values of the GTVs
followed a Gaussian distribution. For each delineated volume, a Gaussian dis-
tribution function was ﬁtted to the histogram of HU values and the Gaussian
distribution mean value was used as a representation of the tumor radiodensity.
For each patient, Figure 6.3 shows the development of tumor radiodensity over
time.
6.2.2 Repeated measurements model
For the acquired data of logarithmic tumor volumes and tumor densities we
perform an analysis of variance investigation for repeated measurements using
SAS software. The aim of the analysis was to investigate how time-dependence
can be modelled for changes in logarithmic tumor volume and tumor density.
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Figure 6.2: Logarithmic tumor volumes as a function of time during treatment
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Figure 6.3: Tumor radiodensity as a function of time during treatment
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We compare (up to) second order polynomial regression models with patient
speciﬁc parameters as well as models with population speciﬁc parameters.
The basic model for changes in logarithmic tumor volume and tumor density
for patient i, where i = 1, ..., k is
Y i =
 Yi,1...
Yi,ni
 =
 1 ti,1 ti1
2
...
...
...
1 ti,ni ti,ni
2

 αiβi
γi
+ εi (6.1)
or
Y i = xiθi + εi (6.2)
where εi has the variance-covariance matrix
D(εi) = Ri = σ
2

1 . . . ρ|ti,1−ti,ni |
...
...
ρ|ti,1−ti,ni | . . . 1
 (6.3)
We assume that Y i is normally distributed with mean xiθi and variance-
covariance matrix Ri, and that Y 1, ...,Y k are independent. This gives the
combined model Y 1...
Y k
 =
 x1 . . . 0... ...
0 . . . xk

 θ1...
θk
+
 ε1...
εk
 (6.4)
or
Y = xθ + ε (6.5)
with
D
 ε1...
εk
 =
 R1 . . . 0... ...
0 . . . Rk
 = R (6.6)
The random variable Y is then multivariate normally distributed, Y ∈ NK(xθ,R)
where K it the total number of observations across all patients. Thus we may
use standard likelihood theory for estimation of parameters and testing of hy-
potheses.
For modeling changes in logarithmic tumor volumes as well as changes in tu-
mor density (expressed in Hounsﬁeld units) we investigate each of the models
displayed in table 6.1.
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Model Fixed eﬀects mean
values
Number of mean
value parameters
Description
M1 αi + βiti,y + γiti,j
2 30 Individual bias
Individual slope
Individual quad.
term
M2 αi + βiti,y + γti,j
2 21 Individual bias
Individual slope
Shared quad. term
M3 αi + βiti,y 20 Individual bias
Individual slope
No quad. term
M4 αi + βti,y 11 Individual bias
Shared slope
No quad. term
M5 αi 10 Individual bias
No slope
No quad. term
Table 6.1: Investigated models for changes in logarithmic tumor volumes as
well as changes in tumor densities
6.2.3 Model selection for ordinary least squares and re-
peated measurements analysis
The most general model for a polynomial ﬁt of the data measured on the 10
patients is an individually-ﬁtted quadratic functions. However, for three of the
patients there were only three data points collected. The quadratic functions
therefore obtain a perfect ﬁt. In total, the quadratic model has 30 parameters
(plus uncertainty parameters) and we have 39 observations. Although we know
in advance that this might be over-modeling the data, it is indeed possible to
estimate all parameters. However, since a possible small value of the residual
sum of squares very likely will be due to the over-ﬁtting, we include models with
quadratic terms only from inquisitive reasons with the prior knowledge thatM1
and M2 are probably unreasonable for this number of data points.
We consider the models M1 −M5 obtained by increasing simpliﬁcation of the
previous models. We may perform a formal successive testing of hypothesis and
alternatives
H0: E(Y ) ∈Mt against H1: E(Y ) ∈Mt−1/Mt for t = 1, ..., 4 (6.7)
The hypothesis testing is done both by means of the usual F-test statistic known
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from the general linear model, corresponding to ρ = 0 in the repeated measure-
ments model, and by means of the asymptotic results for the likelihood ratio
test statistic which in this case basically says that -2 log (likelihood ratio test
statistic Q) under the null hypothesis will be asymptotically χ2 distributed with
degrees of freedom equal to the decrease in number of 'free' parameters from
the more elaborate to the simpler model.
6.3 Results
6.3.1 Investigation of tumor volume changes
Table 6.2 presents the result of the GLM analysis using least squares ﬁts with
independent residuals. Table 6.3 presents the results of the repeated measure-
ments analysis using maximum likelihood ﬁts with autocorrelated residuals.
Model # of mean
value para-
meters
Degrees of
freedom
Residual
SS
F-statistic
f
P(F > f)
M1 30 9 0.108
M2 21 18 0.481 3.43 0.04
M3 20 19 0.481 0.002 0.96
M4 11 28 0.886 1.78 0.14
M5 10 29 2.05 37.7 0.00
Table 6.2: Least squares ﬁts with independent residuals for tumor volume
changes. Model M3 and M4 are accepted.
Model # of mean
value para-
meters
Degrees of
freedom
-2 log like-
lihood
Successive
diﬀerence,
sd
P(χ2 > sd)
M1 30 -119
M2 21 9 -60.8 58.0 0.000
M3 20 1 -60.8 0.010 0.920
M4 11 9 -37.1 23.7 0.005
M5 10 1 -4.50 32.4 0.000
Table 6.3: Maximum likelihood ﬁts with autocorrelated residuals (repeated
measurements analysis) for tumor volume changes. Model M3 is
accepted.
6.3 Results 65
It follows from Table 6.2 and 6.3 that we accept M3 using both methods with
95% conﬁdence1 but only the classical GLM approach accepts M4. As already
stated above we are clearly in a repeated measurements situation, and as such
we put the stronger emphasis on the result in table 6.3 and proceed to conclude
that model M3 is the simplest model adequately describing the development of
the logarithmic tumor volumes. The estimated parameters for model M3 for
repeated measurements are presented in Table 6.4. Figure 6.4 shows the tumor
volumes withM3 regression models ﬁtted. Figure 6.5 shows the distribution and
cumulative distribution of βˆi values for the M3 repeated measurements model
for tumor volume changes. Note that a normal distribution is assumed.
Patient αˆi stderr(αˆi) βˆi stderr(βˆi)
1 5.30 0.103 -0.016 0.004
2 5.71 0.105 -0.010 0.005
3 4.53 0.105 -0.028 0.005
4 4.95 0.105 -0.011 0.004
5 4.80 0.106 0.014 0.004
6 5.21 0.108 -0.012 0.004
7 4.90 0.109 -0.019 0.006
8 4.83 0.103 -0.021 0.006
9 5.36 0.105 -0.021 0.005
10 5.58 0.102 -0.017 0.005
Table 6.4: Estimated patient speciﬁc parameters (bias and slope) for tumor
volume changes for M3 repeated measurements model.
It follows that the main diﬀerence between the two situations is that the estim-
ated errors on the parameters are smaller in the repeated measurements model,
also explaining why we have stronger signiﬁcance in that case. Furthermore we
have for the estimated variance-covariance matrix, D(εi), that
σˆ2 = 0.012, stderr
(
σˆ2
)
= 0.003
ρˆ = −0.238, stderr (ρˆ) = 0.844
6.3.2 Investigation of tumor radiodensity changes
Table 6.5 presents the result of the general linear model (GLM) analysis of tumor
radiodensity changes, using least squares ﬁts with independent residuals. Table
6.6 presents the results of the repeated measurements analysis using maximum
likelihood ﬁts with autocorrelated residuals. We here take M3 as starting point
for our analysis as M1 and M2 over-model the data.
1As the test statistics are higher than 0.05
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Figure 6.4: Delineated tumor volumes as a function of time during treatment,
with M3 linear regression models with patient speciﬁc bias and
slope ﬁtted.
Figure 6.5: Distribution and cumulative distribution of βˆi values for the M3
repeated measurements model for tumor volume changes.
Model # of mean
value para-
meters
Degrees of
freedom
Residual
SS
F-statistic
f
P(F > f)
M3 20 19 971 6.34
M4 11 28 1657 1.49 0.221
M5 10 29 4828 53.6 0.000
Table 6.5: Least squares ﬁts with independent residuals for tumor radiodensity
changes. Model M3 and M4 are accepted.
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Model # of mean
value para-
meters
Degrees of
freedom
-2 log like-
lihood
Successive
diﬀerence,
sd
P(χ2 > sd)
M3 20 236
M4 11 9 256 20.3 0.016
M5 10 1 292 36.6 0.000
Table 6.6: Maximum likelihood ﬁts with autocorrelated residuals (repeated
measurements analysis) for tumor radiodensity changes. ModelM3
is accepted.
It follows from Table 6.5 and 6.6 that only the classical GLM approach ac-
cepts M4. Since we clearly are in a repeated measurements situation, we put
the stronger emphasis on the result in Table 6.6, and thus we conclude that
model M3 is the simplest model adequately describing the development of the
logarithmic tumor radiodensity.
The estimated parameters for M3 for repeated measurements are presented in
Table 6.7. Figure 6.6 shows tumor radiodensities as a function of time, during
treatment, with M3 regression models ﬁtted. It follows that the main diﬀerence
between the two modeling approaches is that the estimated errors on the para-
meters are smaller in the repeated measurements model, also explaining why we
have stronger signiﬁcance in that case. Figure 6.7 shows the distribution and
cumulative distribution of βˆi values for the M3 repeated measurements model
for tumor radiodensity changes. Note that a normal distribution is assumed.
Patient αˆi stderr(αˆi) βˆi stderr(βˆi)
1 51.3 4.65 -0.757 0.196
2 56.2 4.74 -0.889 0.215
3 52.0 4.72 -0.550 0.203
4 59.0 4.74 -1.03 0.199
5 34.1 4.78 -0.404 0.170
6 45.1 4.86 -0.295 0.167
7 61.9 4.90 -1.28 0.271
8 67.5 4.62 -1.44 0.271
9 60.5 4.70 -1.03 0.210
10 39.7 4.57 -0.561 0.217
Table 6.7: Estimated patient speciﬁc parameters (bias and slope) for tumor
radiodensity changes for M3 repeated measurements model.
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Figure 6.6: Tumor radiodensities as a function of time, during treatment, with
M3 linear regression models with patient speciﬁc bias and slope
ﬁtted.
Figure 6.7: Distribution and cumulative distribution of βˆi values for the M3
repeated measurements model for tumor density changes.
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Figure 6.8: Tumor volume against tumor radiodensity for each patient.
6.3.3 Connection between tumor volume and radiodensity
changes
Figure 6.8 shows tumor volume against tumor radiodensity for each patient.
Figure 6.9 shows tumor volume plotted against radiodensity modeling residual
for each patient, with a ﬁtted linear regression line.
6.4 Discussion & Conclusions
We have modelled changes in tumor radiodensity and logarithmic tumor volume.
Both datasets were best described using simple linear models with individual
bias and slope, when modeled using a repeated measurement framework. This
means that we see signiﬁcant changes in both volume and radiodensity and that
these changes do not happen at the same rate for all patients. Interestingly,
using a GLM approach resulted in the acceptance of a simpler model (for this
data set) than the repeated measurements approach. As the data clearly reﬂects
a repeated measurements situation, we put the stronger emphasis on that result.
It was clear from Figure 6.8 that tumor volumes do not decrease in size as a
result of an increase in (radio)density. For all patients, even the one where tumor
volume increased slightly, we observed a decrease in tumor radiodensity. From
Figure 6.9 it can be seen that there is no correlation between tumor volume
and tumor radiodensity that is not explained by the common correlation to the
independent variable, time.
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Figure 6.9: Tumor volume against radiodensity modeling residual for patient
i = 1, ..., 10 indicated with numbers in the ﬁgure. A ﬁtted linear
regression line with 95% conﬁdence interval is shown in red. The
75% prediction ellipsoid is shown in green.
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It is noteworthy that tumor radiodensity changes during the course of radiothe-
rapy have not previously been investigated, and that such changes might need
to be taken into account if/when re-planning patients in adaptive photon radio-
therapy, in addition to tumor volume changes. Tumor density changes might
also be of substantial importance for proton therapy, as dose distributions are
highly dependent on actual tissue density.
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Chapter 7
Spatially Varying
Riemannian Elasticity
Regularization:
Application to Thoracic CT
Registration in
Image-Guided Radiotherapy
T. Bjerre, M.O. Fogtmann, M. Aznar, P. Munck af Rosenschöld, L. Specht and
R. Larsen. 'Spatially varying Riemannian elasticity regularization: Applica-
tion to thoracic CT registration in image-guided radiotherapy'. In: Biomedical
Imaging (ISBI), 2012 9th IEEE International Symposium on, pp. 1224-1227.
Abstract
For deformable registration of CT scans in IGRT we apply Riemannian elasticity
regularization. We explore the use of spatially varying elasticity parameters to
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encourage bone rigidity and local tissue volume change only in the GTV and the
lungs. We evaluate the method on the point-validated 4DCT breathing thorax
POPI-model and demonstrate its use and properties in registration of pre- and
post-chemo CT scans for contour propagation in a Hodgkin lymphoma (HL)
case showing signiﬁcant tumor shrinkage. For the POPI-model we achieved a
total mean target registration error (TRE) of 0.92 ± 0.49 mm. Using spatially
varying regularization for the HL case, deformation was limited to the GTV and
lungs.
7.1 Introduction
In IGRT, dose distribution is planned based on manual contouring of the tumor
and critical normal tissues on a pre-treatment PET/CT scan. Conventional RT
treatment is fractionated; patients receive a daily fraction of the total planned
dose. Throughout the course of treatment, spatial changes of the patient may
cause residual positional errors even after translational and rotational image
guided corrections. Such changes include tumor shrinkage (Erridge et al. 2003;
Barker et al. 2004), weight loss, organ ﬁlling and change in posture, all of which
cause tissue deformation, ultimately disturbing the planned dose distribution.
Hansen et al. 2006 concluded that adaptive replanning is essential for IMRT
treatment for HNCA cancer to ensure proper dose to target volumes and critical
tissues.
Manual tumor re-contouring on a daily basis is unfeasible due to the massive
amount of physician time and eﬀort required. Adaptive RT techniques allow for
automatic, but preferably supervised, correction of these spatial changes on a
daily basis. Contours of the GTV and critical tissues can be propagated by use
of image registration, and the dose distribution can be updated accordingly.
Image registration is the process of determining a spatial transformation that
establishes meaningful correspondence between all points in a pair or set of im-
ages; in this case between the planning PET/CT and a subsequent CT or CBCT
scan. In general, image registration comprises 3 main aspects. 1. Selecting an
image transformation model, T . 2. Selecting an objective function Fobj , includ-
ing an image (dis)similarity measure D and a regularization term R ensuring
a plausible, invertible transformation. 3. Selecting an optimization strategy for
the objective function.
Here, we explore the use of the Riemannian elasticity model for regularization,
proposed by Pennec et al. 2005. Based on a Hounsﬁeld units (HU) threshold
segmentation, Ruan et al. 2006 applied spatially varying regularization encour-
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aging bone rigidity and Kabus et al. 2007 used spatially varying elasticity. In
a similar fashion, we use spatially varying tissue regularization parameters, en-
abling us to encourage local rigidity and volume change. Speciﬁcally, we seek
to exploit the a priori knowledge that volume change is likely to happen in the
GTV.
We evaluate spatially varying Riemannian elasticity regularization on the POPI-
model, a point-validated 4DCT breathing thorax data set, and further illustrate
its use on a HL case with pre- and post-chemotherapy CT scans.
7.2 Data
7.2.1 POPI-model: 4DCT
The POPI-model is a point-validated 4DCT image data set of a breathing
thorax. The dataset was acquired at the Léon Bérard Cancer Center & CREATIS
lab, Lyon, France. It is available at http://www.creatis.insa-lyon.fr/rio/
popi-model and is described by Vandemeulebroucke et al. 2007. The data set
consists of ten volume images, each in a diﬀerent phase of one breathing cycle.
The images are cropped to volumes of 482× 360× 141 voxels at a resolution of
0.98 × 0.98 × 2.0 mm, including only the thorax. Forty landmarks have been
manually annotated in each of the images. Performance is evaluated by calcu-
lating the TRE as the euclidean distance between the points annotated in the
target scan and the deformed points from the reference scan (ﬁrst phase). For
images downsampled to a resolution of 2× 2× 2 mm, a mean TRE for all scans
of 1.24±0.42 was achieved using a non-parametric Demons method from Sarrut
et al. 2006b, inspired by Thirion 1998. A mean TRE of 1.04 ± 0.53 mm was
achieved using a parametric, multi-scale implementation by Delhay et al. 2007
of the FFD deformation model by Rueckert et al. 1999. Glocker et al. 2011
reports a mean TRE of 0.96 ± 0.57 mm (on the downsampled data) using a
discrete graph-based, multi-scale FFD method.
7.2.2 Hodgkin lymphoma case: Pre- and post-chemo CT
A HL patient with a very large mediastinal tumor burden was staged with a
FDG PET/CT scan before the initiation of chemotherapy. Later, the patient
was referred to RT, where a planning CT scan was acquired. In HL, the RT
target volume is the PET-positive volume as it was deﬁned on the staging (pre-
chemotherapy) scan. However, between the staging and planning scan, the
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tumor burden is likely to have been reduced considerably, the patient is likely
to have lost weight and the posture is likely to vary. Automatic deformable
registration and propagation of the PET-positive contour to the RT planning
CT would be a valuable aid to the physician, when deﬁning the radiation target
volume.
7.3 Method
We applied a SSD driven FFD B-spline model (Rueckert et al. 1999) to register
the staging and planning CT scans allowing for a subsequent mapping of the
GTV contour to the planning CT. The use of the cubic B-spline deformation
model is motivated partly by the existence of direct analytic continuous deriv-
atives and partly by the inherent dimensionality reduction. We believe that the
B-spline deformation model has enough descriptive power to capture the true
underlying deformations between the scans as we are estimating the mapping
between images of the same subject. In a multi-level framework, an L-BFGS
(Liu et al. 1989) algorithm was applied to solve the matching problem, i.e.
min
φ
D(R, T ◦ φ) +R(φ), (7.1)
where D is the SSD (di)similarity measure, R is the reference (staging CT),
T is the target (planning CT), φ is the B-spline transformation and R is the
regularization term.
Biological studies, e.g. (Hu 2006; Sarma et al. 2003), show that biological
tissue is similar to rubber; nearly incompressible and compliant to shear. Thus
a rubber-like deformation prior is suitable for same-subject registration when
images are acquired temporally close. However, cancer patients are likely to have
signiﬁcant weight loss, have tumor shrinkage and tissue loss in proximity to the
tumor regions which makes the incompressibility constraint invalid. Relaxing
the incompressibility constraint transforms the rubber prior into a more general
elasticity prior.
Linear elasticity matching (Broit 1981) has been widely used for spatial normal-
ization but the lack of local rotation invariance can hinder optimal matching.
Especially in HNCA imaging, the neck posture (bending in the neck) may cause
the linear elasticity prior to over-regularize the deformation. We applied an iso-
tropic Riemannian elasticity prior by Pennec et al. 2005, with spatially varying
elasticity parameters as a trade-oﬀ between modelling capability and simpli-
city. The Riemannian elasticity prior is a simple weighted quadratic penalty
on the Hencky strain tensor which inherits local rotational invariance and the
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inﬁnity energy limit approaches the black-hole deformation. While biological
tissue is elastically anisotropic, anisotropic modeling requires many parameters
which cannot be estimated from CT scans alone. Instead, isotropic behaviour is
assumed, reducing the number of parameters to two  namely the usual Lamé
parameters µ, λ, giving the isotropic Riemannian elasticity
Rrie(µ, λ;φ) = µ
4
N∑
i=1
log2 εi +
λ
8
(
N∑
i=1
log εi
)2
, (7.2)
where µ controls the amount of elastic potential due to shearing, and λ controls
the amount of elastic potential due to local compression or expansion. εi are the
principal stretches. In contrast to linear elasticity and Saint-Vernant Kirchoﬀ
elasticity λ is solely related to local volume change (Hansen 2009). The Lamé
parameters are set experimentally for each tissue type (bone, soft tissue, lung)
which are segmented from the planning CT using HU intensity thresholding. In
addition, the Lamé parameters are set low in the GTV to allow for considerable
shrinkage. The image maps of Lamé parameters are smoothed to get smooth
elastic potential transitions.
7.4 Results
7.4.1 POPI-model
For the FFD transformation model, Glocker et al. 2011 used multi-level control
point spacing of 40, 20, 10, 5 mm. We have used two registration levels with 20
and 10 mm spacing. Additional registration levels did not improve performance.
Level 1 used downsampling to 4× 4× 4 mm and level 2 used downsampling to
2 × 2 × 2 mm. Table 7.1 presents the registration results using both spatially
constant and varying regularization. For spatially varying regularization, the
provided segmentation of the lung was used together with a HU-based bone
segmentation for assigning local Lamé regularization parameters. Rigidity was
encouraged only for bone, by setting µbone  µsoft tissue, µlung. Volume change
was encouraged only for lung by setting λlung  λsoft tissue, λbone.
7.4.2 Pre- and post-chemo CT
For spatially varying regularization, triangulation-based GTV segmentation and
HU-based segmentation of bone, soft tissue and lung was used for assigning
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Figure 7.1: Overlay of transverse slice of pre-chemo CT and deformed post-
chemo CT. The red, dotted line is the PET-positive contour.
Table 7.1: POPI-model registration results
#
Initial mean
distance [mm]
mean TRE [mm]
(spatially constant)
mean TRE [mm]
(spatially varying)
1 0.48± 0.54 0.65± 0.33 0.64± 0.31
2 0.49± 0.62 0.65± 0.42 0.63± 0.39
3 2.19± 1.84 1.19± 0.68 1.19± 0.70
4 4.33± 2.54 1.01± 0.50 1.02± 0.50
5 5.75± 2.67 1.08± 0.62 1.08± 0.63
6 6.10± 2.96 0.98± 0.53 1.00± 0.54
7 5.03± 2.36 1.08± 0.50 1.09± 0.53
8 3.68± 1.59 0.80± 0.40 0.77± 0.41
9 2.07± 1.07 0.84± 0.42 0.82± 0.43
All 3.35± 2.82 0.92± 0.49 0.92± 0.49
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Figure 7.2: Volume change in the transverse slice in 7.1. Values of 1 indicate
no local volume change. The black contour is gradients extracted
from the CT.
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Figure 7.3: Post-chemo CT with manually propagated and adapted contour
(red) and contours propagated automatically using spatially con-
stant (blue) and varying (green) regularization.
local Lamé regularization parameters. Rigidity was encouraged only for bone,
by setting µbone  µsoft tissue. Volume change was encouraged for both GTV
and lung by setting λGTV, λlung  λsoft tissue, λbone. Figure 7.1 displays a fusion
of a single transverse slice of the pre-chemo CT and the deformed post-chemo
CT. Figure 7.2 shows the Jacobian determinant of the transformation ﬁeld,
i.e. the local volume change, in the same slice. The initial tumor volume was
140cm2. Using spatially constant regularization, the volume of the propagated
contour was 120cm2. Using spatially varying regularization, the volume of the
propagated contour was 99cm2. Comparing segmentations from the propagated
contours to a manual post-chemo GTV segmentation resulted in Dice similarity
coeﬃcients of 0.43 in both cases versus 0.39 using rigid registration.
7.5 Discussion & Conclusion
For the POPI-model we achieved a total mean TRE smaller than what has
been reported in the literature. The standard deviation is also small. For the
breathing phases with low initial mean distance, deformation resulted in a mean
TRE larger than the initial distance. This was expected as the registration was
based on downsampled images. The standard deviation, however, was signi-
ﬁcantly decreased in these cases. There was no diﬀerence between the results
obtained using spatially constant and varying regularization, most likely due to
the absence of signiﬁcant volume changes. In that respect, this data set is not
troublesome. For the HL case we demonstrated that local volume change can
be encouraged in volumes where it is expected (GTV, lungs, etc.). The Dice
similarity coeﬃcients between the manual post-chemo GTV segmentation and
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those based on deformable registration were relatively low, primarily due to the
clinician choosing to include a larger area on the planning scan. Still, the coeﬃ-
cients were higher than that of the rigid registration, suggesting that this would
be a better starting point for the clinician who is manually propagating and
modifying the contour. By visual inspection it is apparent that qualitatively,
the registration result using spatially varying regularization is superior. The
method could very well be suitable for registration to low-quality scans with de-
ranged image gradients, in order to minimize local volume change, e.g. CBCT
scans for daily contour propagation in adaptive RT. As with all parametric
image registration methods, the main drawback is parameter optimization. In
this regard, the use of spatially varying regularization parameters is a further
encumbrance.
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Chapter 8
Demons Registration of CT
Volume and CBCT
Projections for Adaptive
Radiotherapy: Avoiding
CBCT Reconstruction
T. Bjerre, M. Aznar, P. Munck af Rosenschöld, L. Specht, R. Larsen, M.O. Fogt-
mann. 'Demons registration of CT volume and CBCT projections for adaptive
radiotherapy: Avoiding CBCT reconstruction'. In: Radiotherapy and Oncology,
103 (2012), pp. S561-S562.
Purpose
In ART, the dose plan is adapted throughout the fractionation schedule to ac-
commodate for anatomical changes. This can be achieved by deformable image
registration of the planning PET/CT scan with segmented tumor and organs to
daily CBCT scans. CBCT scans, are typically reconstructed using the ﬁltered
back-projection algorithm, which introduces signiﬁcant artefacts, causing deteri-
orated image quality and registration results. We study the feasibility of per-
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forming demons registration without tomographic reconstruction of the CBCT
projections.
Materials
We demonstrate demons registration (Thirion 1998) of a CT volume and CBCT
projections of the same subject. For simplicity, instead of measured projections,
we used synthetic projections of the CT deformed by a known deformation. A
volume from Vandemeulebroucke et al. 2007 was used 1. The iterative registra-
tion is performed by repeating steps 1-4:
1. Simulate CBCT projections of deformed planning CT.
2. Back-project diﬀerence between simulated and measured projections.
3. Perform demons update based on back-projected diﬀerence.
4. Apply deformation to the planning CT.
We used an additive demons update schemes with adaptive ﬂuidity (smoothing
kernel width). For forward/back-projection, the separable footprints algorithm
with trapezoid functions was applied. The similarity between the simulated and
measured projections was measured as the SSD.
Results
Figure 8.1 shows a slice of; the CT volume (reference), the CT deformed by
the known deformation (target), the relative Euclidean error of the true and
estimated deformation ﬁelds, and the CT volume registered to the projections
of the deformed CT. Interestingly, the deformation was accurately estimated
from only 24 projections. The MSE between the target and registered image was
1.4 ·10−3 HU2. The mean absolute diﬀerence between the Jacobian determinant
of the true and estimated deformation ﬁeld was 4 ·10−4. Time consumption was
11 min. using 8 2.3 GHz AMD Opteron cores.
Conclusion
In this feasibility study, using a known deformation and synthetic noise-less pro-
jection data, it was possible to estimate the deformation with good accuracy.
For real projection data it might be necessary to use the mutual information sim-
ilarity measure. Using few projections, daily dose burden could be decreased,
or photon ﬂuence for each projection increased. Time consumption was low
compared to the alternative scheme of iterative reconstruction followed by re-
gistration, but can be reduced by further code parallelisation.
1The Léon Bérard Cancer Center & CREATIS Lab, Lyon France.
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Chapter 9
Three-dimensional
MRI-linac intra-fraction
guidance using multiple
orthogonal cine-MRI planes
T. Bjerre, S. Crijns, P. Munck af Rosenschöld, M. Aznar, L. Specht, R. Larsen
and P. Keall. 'Three-dimensional MRI-linac intra-fraction guidance using mul-
tiple orthogonal cine-MRI planes'. In: Physics in medicine and biology, 58.14
(2013), pp. 4943-4950.
Abstract
Introduction: The introduction of integrated MRI-radiation therapy systems
will oﬀer live intra-fraction imaging. We propose a feasible low-latency multi-
plane MRI-linac guidance strategy. In this work we demonstrate how interleaved
acquired, orthogonal cine-MRI planes can be used for low-latency tracking of
the 3D trajectory of a soft-tissue target structure. Methods: The proposed
strategy relies on acquiring a pre-treatment 3D breath-hold scan, extracting a
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3D target template and performing template matching between this 3D tem-
plate and pairs of orthogonal 2D cine-MRI planes intersecting the target motion
path. Results: For a 60 second free-breathing series of orthogonal cine-MRI
planes, we demonstrate that the method was capable of accurately tracking the
respiration related 3D motion of the left kidney. Quantitative evaluation of the
method using a dataset designed for this purpose revealed a translational error
of 1.15 mm for a translation of 39.9 mm. Conclusions: We have demonstrated
how interleaved acquired, orthogonal cine-MRI planes can be used for online
tracking of soft tissue target volumes.
Online supplementary data available from http://stacks.iop.org/PMB/58/
4943/mmedia
9.1 Introduction
Integrated MRI-radiotherapy systems are currently under development, as de-
scribed by Lagendijk et al. 2008, Raaymakers et al. 2009, Fallone et al. 2009,
Dempsey et al. 2011, Dempsey et al. 2005. While not widely available, such
systems oﬀer live intra-fraction imaging, thus facilitating non-invasive, non-
surrogate based, low-latency tumor motion tracking with no additional imaging
radiation dose. Online tracking of target volumes in image-guided radiotherapy
(IGRT) has great potential to increase conformality when treating tumors af-
fected by respiratory motion. Tumor dose is thereby maximized while the dose
to surrounding healthy tissue is minimized, Verellen et al. 2007. This enables
dose escalation, providing for a higher tumor control probability.
The AAPM Task Group 76 report by Keall et al. 2006 concluded that lung tu-
mors can follow complex 3D trajectories. An intra-fraction tracking method
should therefore preferably provide 3D coordinates of the tumor. Possible
breathing irregularities necessitate that the latency of an online tracking system
be kept as low as possible. Keall et al. 2006 suggest that an upper latency limit
for an online tracking system should be 0.5 seconds. Ries et al. 2010 show that
an MRI tracking system with a 10 Hz imaging rate, 100 ms processing latency
and a Kalman predictor provides a 0.9 mm tracking error for tracking the mo-
tion of a kidney. Such tracking error will be close to the voxel size delivered by
most MRI systems.
Acquisition of high-quality live 3D images with subsequent low-latency deform-
able image registration (DIR) would be optimal, but is currently not feasible
due to the lack of appropriate MRI acquisition sequences and DIR algorithms.
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Previous eﬀorts have focused on tracking in 2D cine-MRI planes. Cerviño et al.
2011 suggested the use of template matching for real-time lung tumor tracking
in sagittal cine-MRI scans. An inherent drawback of tracking a 3D structure in a
2D plane is the inability to detect out-of-plane motion. They suggest addressing
out-of-plane motion by surrogate tracking of the diaphragm. Yun et al. 2012b
investigated the use of an intra-fractional lung tumor auto-contouring algorithm
for a phantom study using sagittal cine-MRI planes. Yun et al. 2012a describes
how the auto-contouring algorithm of Yun et al. 2012b can be extended with an
artiﬁcial neural network (ANN)-based motion prediction algorithm.
Ries et al. 2010 performed 3D target tracking by combining 2D-plane imaging
with prospective slice tracking based on pencil-beam navigator sequences. The
eﬀect of the update latency was reduced using a Kalman-predictor for trajectory
anticipation. One limitation they ﬁnd is that since the detected beam signal is
predominantly spin-density weighted, it suﬀers from poor tissue contrast, which
can potentially lead to poor tracking performance.
We have developed and investigated a 3D tracking strategy feasible for low-
latency, intra-fraction magnetic resonance imaging-linear accelerator (MRI-linac)
guidance. The proposed strategy is based on template matching between a 3D
target template obtained from a pre-treatment breath-hold MRI scan and sets
of orthogonal cine-MRI planes. We use interleaved acquired coronal and sagittal
cine-MRI scan planes, intersecting the motion path of the tracked structure in
the subject.
We seek to illustrate that the method facilitates 3D motion tracking, that the
use of orthogonal planes is superior to tracking 2D target templates on a single
cine-MRI plane, and that the method is feasible for online tracking of soft tissue
target volumes.
9.2 Methods
The clinical scenario under which this method would operate involves the ac-
quisition of a pre-treatment breath-hold 3D MRI scan from which a 3D template
containing the target is extracted.
The similarity between the 3D template and pairs of cine-MRI 2D coronal and
sagittal planes is calculated for each combination of investigated [posterior-
anterior (PA), right-left (RL), inferior-superior (IS)] translations of the 3D tem-
plate. If the resolution of the 3D template diﬀers from the resolution of the 2D
planes, interpolation is required.
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The 3D bounding box, VC, with dimensions NPA×NRL×NIS encompasses the
entire irregularly shaped target volume VT .
The 3D target template can be thought of as a set of 2D coronal target slices
as well as a set of sagittal target slices encompassing the segmented target
Scor = {scor,1, .., scor,NPA}, (9.1)
Ssag = {ssag,1, .., ssag,NRL}, (9.2)
where each slice spans the target volume in that particular orientation and plane,
e.g.
scor,1 = VC(1, iRL, iIS) (9.3)
iRL = [minRL − b, ..,maxRL + b] (9.4)
iIS = [minIS − b, ..,maxIS + b)], (9.5)
where minRL,maxRL,minIS,maxIS are the minimum and maximum voxel indices
of segmented target volume voxels in that particular slice. This means that the
set of target slices in one orientation are not necessarily of the same dimension.
Here, b is an additional border that can be added to improve tracking robustness
if necessary. On the other hand, adding too wide a border might deteriorate
accuracy.
For each set of interleaved acquired coronal and sagittal 2D cine-MRI planes,
Pcor, Psag, a similarity measure is evaluated between Pcor and the individual
slices of the coronal target slice set Scor and between Psag and the slices of Ssag.
The similarity measure is evaluated for all investigated combinations of PA, RL
and IS translations of the target template, with TPA, TRL, TIS being the total
number of investigated translations in each direction. This results in TPA 2D
coronal similarity arrays dcor of size TRL × TIS and TRL 2D sagittal similarity
arrays dsag of size TPA × TIS. The arrays are normalized by subtracting each
array by the lowest of the array itself.
The coronal and sagittal 2D similarity arrays are coalesced into two 3D similarity
arrays, Dcor, Dsag both of size TPA × TRL × TIS. Subsequently, the combined
similarity array, Dtotal, is determined by adding the normalized coronal and
sagittal similarity arrays,
Dtotal = Dcor,normalized +Dsag,normalized. (9.6)
The optimal translation is the one with the highest combined similarity measure,
max
t
(Dtotal)⇒ toptimal. (9.7)
The normalization is performed in order for the similarity values of the coronal
and sagittal array to be approximately on the same scale. If not normalized, one
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array might dominate Dtotal. If the orthogonal slices have diﬀerent resolutions,
further normalization might be needed.
As similarity measure for the template matching we applied mean-absolute-
diﬀerence (MAD). Other methods, including mean-squared-error (MSE) and
normalized cross-correlation (NCC) were considered, but generally gave inferior
results for the data at hand. Note that MAD and MSE are actually dissimilarity
measures for which equation 9.6 is minimized in order to maximize similarity.
Breath-hold scans and cine-MRI scans were acquired using the same sequence
so that normalization was not required. In order to apply traditional template
matching algorithms, the template was interpolated to the same pixel size as
the orthogonal planes.
A basic assumption for this method is local rigidity of the target volume. The
method should be suitable for target sites where this approximately holds. We
acquired coronal and sagittal planes, but all directions could be used, as long
as the tracked structure is intersected by the orthogonal planes at all times. If
the target volume is too small to ensure this, additional border can be added to
the target template as described above.
9.2.1 Qualitative evaluation
For a qualitative evaluation of the method, we acquired a 3D exhale MRI scan
and a series of interleaved acquired orthogonal cine-MRI planes. We segmented
the 3D target structure from the exhale scan by manual delineation, and then
performed tracking on all pairs of cine planes in a one-minute sequence, thus
estimating the position of the target center in 3D. Since the true position of the
target volume center in 3D cannot be known during this type of acquisition, the
result is evaluated using visual inspection, by superimposing the target volume
delineation on the cine-MRI scans according to the estimated translation of the
volume.
The true position can only be known for acquisition of 3D volumes with no
motion, ie. during breath-hold or using very fast sequences with inherently
poor signal-to-noise ratio.
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9.2.2 Quantitative evaluation
In order to quantify the accuracy of the method, we acquired 3D inhale and ex-
hale breath-hold MRI scans and segmented the target structure in both breath-
ing phases by manual delineation. This gives us the true diﬀerence in position of
the target structure in these two breath-hold states. We then compared the true
diﬀerence in location of the center of the target volume to the one approximated
using tracking of the 3D target template from the exhale scan on a sagittal and
coronal slice pair, extracted from the 3D inhale breath-hold scan. This approach
simulates tracking on cine-MRI planes while knowing the actual true position
of the target center of volume.
The true diﬀerence in location of the target center of volume is established by
delineating the 3D target volume in the 3D inhale and exhale scans, calculating
the center of the target volume and calculating the posterior-anterior, right-left
and inferior-superior diﬀerences in location.
We compared our multi-plane 3D tracking method to 2D tracking as demon-
strated by Cerviño et al. 2011. This was done by using the segmented target
on one sagittal or coronal slice in the exhale scan as template and tracking this
template in the same coronal or sagittal slice plane of the inhale scan.
9.2.3 Data for qualitative evaluation
This method is applicable to all tumor sites aﬀected by respiratory motion.
We tested the method in a healthy subject, tracking the left kidney during
respiration.
All data was acquired on a 1.5T Philips Achieva system using an 8 channel torso
receive coil.
The orthogonal cine-MRI planes were interleaved acquired during free breathing
using a balanced steady-state free precession (bSSFP) sequence with the follow-
ing parameters TR/TE = 2.7/1.34 ms, FOV = 40 × 40 cm, ﬂip angle = 35◦,
slice thickness = 7 mm, in-plane voxel size = 1.05 mm, parallel imaging factor
2, acquisition time per plane = 0.252 s.
At the intersection between the orthogonal planes, less signal is received which
results in a dark line. This is compensated for prior to the template matching,
by multiplying each line of the cine-MRI plane by 1 + 0.4 ∗ G, where G =
exp(−0.5 · x−cw ) is a (non-normalized) 1D Gaussian kernel with a kernel width of
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3 pixel widths and center c at the intersection between the orthogonal planes.
The optimal kernel width has been chosen by visual inspection. This is an ad
hoc empirical solution.
A 3D exhale breath-hold scan was acquired using a bSSFP sequence similar to
the one used for the cine-MRI planes using the following parameters TR/TE
= 2.7/1.34 ms, FOV = 12 × 31 × 31 cm (PA, LR, IS), ﬂip angle = 35◦, slice
thickness = 2 mm, in-plane voxel size = 1.1 mm, acquisition time = 25 s.
The target structure, the left kidney, was manually contoured using the Varian
Eclipse software (Varian Medical Systems Inc.). For a clinical implementa-
tion, target auto-segmentation could be employed. Using Matlab for further
pre-processing, the 3D scan was interpolated to the same resolution as the or-
thogonal cine-MRI planes, and ﬁltered with a Gaussian kernel for improving
tracking robustness. By applying this low pass ﬁltering operation we sought to
ensure that the algorithm reach a global similarity maximum and not a local
one by enhancing the dominant features of the template.
9.2.4 Data for quantitative evaluation
3D exhale and inhale breath-hold scans were acquired using the same 3D se-
quence as for the qualitative evaluation data. The target structure, the left
kidney, was manually contoured in both scans and pre-processed in the same
manner as the scan for qualitative evaluation.
9.3 Results
9.3.1 Qualitative evaluation
Fig. 9.1 displays the measured translation of the left kidney during a one-minute
interleaved acquisition sequence of coronal and sagittal cine-MRI planes. The
initial use of no additional voxel border on the sets of target slices resulted in
a few deviations (discontinuities of center of volume trajectory). By using a
border width of 3 voxels these few deviations were avoided due to added robust-
ness. By visual inspection, tracking accuracy on the remaining frames did not
seem deteriorated by the use of the border. Correlation between the time-series
of inferior-superior and posterior-anterior translation was −0.83. Correlation
between inferior-superior and right-left translation was 0.83. The maximum
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Figure 9.1: This ﬁgure displays posterior-anterior, right-left and inferior-
superior translation of the left kidney as a function of time dur-
ing free breathing. In the plot of inferior-superior position the
peaks represent exhalation while the troughs represent inhalation.
The translation was determined using the multi-plane guidance
method for pairs of interleaved acquired coronal and sagittal cine-
MRI planes. Acquisition frequency was 4 Hz.
peak-to-peak translations in [PA, LR, IS] directions were [4.2, 3.2, 16] mm re-
spectively. The standard deviation of target position in [PA, LR, IS] directions
were [0.70, 0.75, 3.8] mm respectively.
Fig. 9.2 displays two pairs of coronal and sagittal cine-MRI planes from the se-
quence. The 3D kidney delineation from the exhale breath-hold scan is superim-
posed on the cine-MRI planes, according to the translation providing maximum
similarity, using our multi-plane 3D tracking method.
See supplementary material for a video that shows all orthogonal cine-MRI pairs
of the acquired one-minute sequence with superimposed delineation.
The mean processing time for a slice pair was 153 ms for a 53× 83× 111 voxel
template with a non-parallelized Matlab implementation on an Intel I7-620M
processor.
9.3.2 Quantitative evaluation
Table 9.1 presents the results of the quantitative evaluation. The table compares
the diﬀerence in accuracy between 3D tracking on orthogonal cine-MRI planes
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Figure 9.2: For two points in time during free breathing, t = [7, 45.25] seconds,
this ﬁgure displays pairs of interleaved acquired coronal and sagit-
tal cine-MRI planes. The 3D kidney delineation from the exhale
breath-hold scan is superimposed on the cine-MRI planes (solid
white), according to translation determined using our multi-plane
3D tracking method. The dotted white lines are at the same po-
sitions in the scans and are included only to emphasize the soft
tissue motion between the time points.
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True diﬀerence
in location [mm]
Appr. diﬀerence [mm] Error [mm]
S C S+C S C S+C
Posterior-Anterior 10.5 9.38 0 9.38 1.09 10.5 1.09
Right-Left -3.46 0 -6.25 -3.13 -3.46 2.79 -0.34
Inferior-Superior -38.3 -38.5 -38.5 -38.5 0.20 0.20 0.20
Total (Euclidean) 39.9 39.7 39.0 39.8 3.63 10.8 1.15
Table 9.1: This table compares the true diﬀerence in location of the center
of volume of the left kidney between 3D inhale and exhale breath-
hold MRI scans with the approximated diﬀerence in location. The
diﬀerence is approximated using 3D tracking of the 3D kidney tem-
plate from the exhale scan on a sagittal and coronal slice pair from
the inhale scan, emulating cine-MRI planes (denoted by S+C) as
well as by using 2D tracking of single sagittal or coronal slice kid-
ney templates from the exhale scan tracked on the same sagittal
or coronal slice of the inhale scan (denoted S and C respectively).
The calculated error is the Euclidean diﬀerence between the true
and estimated position.
and 2D tracking on a single sagittal or coronal plane.
The use of diﬀerent border widths around the delineated area in the slices of
the 3D template was investigated. The use of no border gave the most accurate
result.
9.4 Discussion & Conclusions
We have developed a low-latency MRI-linac guidance strategy, feasible for intra-
fraction image-guidance during radiotherapy. Obtaining low-latency informa-
tion about the 3D target trajectory is the single most important feature of our
multi-plane tracking method.
Intra-fraction image guidance allows for improved conformality and maximiza-
tion of the therapeutic ratio by increasing dose to target tissues and decreasing
dose to healthy tissue. We have shown that by using orthogonal, interleaved
acquired cine-MRI planes it is possible to track the 3D trajectory of a soft
tissue target structure. From visual inspection, tracking of the kidney in the
one-minute cine-MRI sequence appears very accurate and robust.
It is interesting but not surprising that there was a relatively large correlation
between motion in the 3 dimensions. However, based on the translations in
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Fig. 1, it is not possibly to predict the P-A and L-R translations from the I-S
translation alone.
The quantitative evaluation results indicate errors of total 3D motion on the
scale of the width of a cine-MRI pixel (1.04 mm). The use of orthogonal planes
was superior to using only a sagittal or coronal plane. Investigations using 3D
breath-hold scans at diﬀerent inhalation states or 4D MRI could be used to
further validate these results. This is merely the overall translational error,
assuming local rigidity, and does not reﬂect on any delineation uncertainty or
deformation between the phases, nor the uncertainty related to the breath-hold
acquisition.
It is noteworthy that any number and orientation of intersecting live planes
could be used, as long as the target is intersected by the planes at all times.
Further investigation on a variety of patient cases and target sizes/locations
will be needed to more broadly characterize the performance of this guidance
strategy.
The use of two orthogonal cine-MRI planes inherently increases the time between
two successive scans of the same plane. In cases with linear trajectory of the
target volume it would be possible to avoid the out-of-plane motion when using
a single cine-MRI plane by choosing an appropriate orientation. In these cases,
using a single cine-MRI plane could be superior to using the proposed multi-
plane method due to the higher temporal resolution.
The processing time for the current implementation allows the total system
delay to be below the 0.5 seconds prescribed by Keall et al. 2006, thus allowing
the method to be fast enough for online tracking. It should be straightforward to
implement parallel processing for a further reduction of processing time. Par-
allel processing could also facilitate rotation-invariant template matching by
processing 3D templates with diﬀerent rotation. For further robustness, and in
order to prevent any eventual deviations, the described method could be exten-
ded with a prediction algorithm. The adoption of a scale-space strategy might
be appropriate for improving tracking robustness and further reduce processing
time, see e.g. Witkin 1984.
While this work focuses on MRI-linac guidance, the described method is relevant
for other applications as well, including MRI high-intensity focused ultrasound
(HIFU) systems.
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